Core Laboratories 10-K 12 Feb 25 2024 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2024	Jan. 31, 2025	Jun. 30, 2024
Cover [Abstract]
Entity Registrant Name	CORE LABORATORIES INC.
Entity Central Index Key	0001958086
Trading Symbol	CLB
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Document Period End Date	Dec. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	Yes
Entity Public Float			$ 938,376,082
Entity Common Stock, Shares Outstanding		46,826,820
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Current Reporting Status	Yes
Entity File Number	001-41695
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	6316 Windfern Road
Entity Address, City or Town	Houston
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77040
City Area Code	713
Local Phone Number	328-2673
Document Annual Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common Stock (par value $0.01)
Security Exchange Name	NYSE
Entity Tax Identification Number	98-1164194
Documents Incorporated by Reference	The information required by Part III of this Report, to the extent not set forth herein, is incorporated herein by reference from the registrant’s definitive proxy statement relating to the Annual Meeting of Shareholders to be held in 2025 , which definitive proxy statement shall be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this Report relates
Auditor Firm ID	185
Auditor Location	Houston, TX
Auditor Name	KPMG LLP
Auditor Opinion	Opinion on the Consolidated Financial Statements We have audited the accompanying consolidated balance sheets of Core Laboratories Inc and subsidiaries (the Company) as of December 31, 2024 and 2023, the related consolidated statements of operations, comprehensive income, changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2024, and the related notes and financial statement schedule II (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2024, in conformity with U.S. generally accepted accounting principles. We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 12, 2025 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting. Opinion on Internal Control Over Financial Reporting We have audited Core Laboratories Inc. and subsidiaries' (the Company) internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2024 and 2023, the related consolidated statements of operations, comprehensive income, changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2024, and the related notes and financial statement schedule II (collectively, the consolidated financial statements), and our report dated February 12, 2025 expressed an unqualified opinion on those consolidated financial statements.
Document Financial Statement Error Correction [Flag]	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 19,157	$ 15,120
Accounts receivable, net of allowance for credit losses of $3,192 and $2,280 at 2024 and 2023, respectively	111,761	109,352
Inventories	59,402	71,702
Prepaid expenses	10,176	8,153
Income taxes receivable	15,594	13,716
Other current assets	10,516	5,093
TOTAL CURRENT ASSETS	226,606	223,136
PROPERTY, PLANT AND EQUIPMENT, net of accumulated depreciation of $314,317 and $315,796 at 2024 and 2023, respectively	97,063	99,626
RIGHT OF USE ASSETS	56,488	53,842
INTANGIBLES, net of accumulated amortization and impairment of $19,326 and $18,825 at 2024 and 2023, respectively	6,403	6,926
GOODWILL	99,445	99,445
DEFERRED TAX ASSETS, net	69,613	69,201
OTHER ASSETS	34,788	34,219
TOTAL ASSETS	590,406	586,395
CURRENT LIABILITIES:
Accounts payable	34,549	33,506
Accrued payroll and related costs	22,901	18,791
Taxes other than payroll and income	7,106	5,939
Unearned revenues	9,332	4,755
Operating lease liabilities	10,690	10,175
Income taxes payable	4,851	7,280
Other current liabilities	8,157	7,651
TOTAL CURRENT LIABILITIES	97,586	88,097
LONG-TERM DEBT, net	126,111	163,134
LONG-TERM OPERATING LEASE LIABILITIES	43,343	42,076
DEFERRED COMPENSATION	31,115	30,544
DEFERRED TAX LIABILITIES, net	13,783	12,697
OTHER LONG-TERM LIABILITIES	20,732	20,040
COMMITMENTS AND CONTINGENCIES
EQUITY:
Preference stock, 6,000,000 shares authorized, $0.01 par value; none issued or outstanding	0	0
Common stock, 200,000,000 shares authorized, $0.01 par value, 46,966,868 issued and 46,826,820 outstanding at 2024; 46,938,557 issued and 46,856,536 outstanding at 2023	470	469
Additional paid-in capital	109,547	110,011
Retained earnings	150,280	120,756
Accumulated other comprehensive income (loss)	(5,769)	(4,972)
Treasury stock (at cost), 140,048 and 82,021 at 2024 and 2023, respectively	(2,537)	(1,449)
Total Core Laboratories Inc. shareholders' equity	251,991	224,815
Non-controlling interest	5,745	4,992
TOTAL EQUITY	257,736	229,807
TOTAL LIABILITIES AND EQUITY	$ 590,406	$ 586,395

Consolidated Balance Sheets Par

Consolidated Balance Sheets Parenthetical - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 3,192	$ 2,280
Accumulated Depreciation	314,317	315,796
Accumulated amortization	$ 19,326	$ 18,825
Preferred stock, par value per share	$ 0.01	$ 0.01
Preferred stock, shares authorized	6,000,000	6,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.01	$ 0.01
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares, issued	46,966,868	46,938,557
Common shares, outstanding	46,826,820	46,856,536
Treasury stock (at cost)	140,048	82,021

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
REVENUE:
Revenue	$ 523,848	$ 509,790	$ 489,735
OPERATING EXPENSES:
General and administrative expense, exclusive of depreciation expense shown below	39,770	40,259	38,117
Depreciation	14,449	15,294	16,476
Amortization	504	490	685
Other (income) expense, net	(9,953)	(850)	(722)
OPERATING INCOME	58,556	54,640	41,524
Interest expense	12,369	13,430	11,570
Income before income taxes	46,187	41,210	29,954
Income tax expense	14,034	4,185	10,296
Net income	32,153	37,025	19,658
Net income attributable to non-controlling interest	753	350	205
Net income attributable to Core Laboratories Inc.	$ 31,400	$ 36,675	$ 19,453
EARNINGS PER SHARE INFORMATION:
Basic earnings per share	$ 0.69	$ 0.79	$ 0.42
Basic earnings per share attributable to Core Laboratories Inc.	0.67	0.79	0.42
Diluted earnings per share	0.67	0.78	0.42
Diluted earnings per share attributable to Core Laboratories Inc.	$ 0.66	$ 0.77	$ 0.42
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic	46,897	46,683	46,334
Diluted	47,685	47,523	46,813
Service [Member]
REVENUE:
Revenue	$ 388,205	$ 371,914	$ 346,974
OPERATING EXPENSES:
Cost of services and product sales exclusive of depreciation expense shown below	297,324	282,135	274,297
Product [Member]
REVENUE:
Revenue	135,643	137,876	142,761
OPERATING EXPENSES:
Cost of services and product sales exclusive of depreciation expense shown below	$ 123,198	$ 117,822	$ 119,358

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 32,153	$ 37,025	$ 19,658
Gain on fair value of interest rate swaps	0	0	6,015
Interest rate swap amount reclassified to net income	(1,040)	(492)	998
Income tax (expense) benefit on interest rate swaps reclassified to net income	219	103	(1,144)
Total interest rate swaps	(821)	(389)	5,869
Amortization of actuarial gain (loss) reclassified to net income	32	(1,130)	603
Income tax (expense) benefit on pension and other postretirement benefit plans reclassified to net income	(8)	324	(116)
Total pension and other postretirement benefit plans	24	(806)	487
Total other comprehensive income (loss)	(797)	(1,195)	6,356
Comprehensive income	31,356	35,830	26,014
Comprehensive income attributable to non-controlling interests	753	350	205
Comprehensive income attributable to Core Laboratories Inc.	$ 30,603	$ 35,480	$ 25,809

Consolidated Statements of Chan

Consolidated Statements of Changes in Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Non-Controlling Interest	Common Stock Outstanding
Balance at Beginning of Period at Dec. 31, 2021	$ 161,001	$ 1,188	$ 101,120	$ 68,349	$ (10,133)	$ (4,075)	$ 4,552
Balance at Beginning of Period (shares) at Dec. 31, 2021		46,454,264				(104,867)		46,349,397
New share issuance	0	$ 6	(6)
New share issuance (shares)		244,838						244,838
Change in par value		$ 0
Change in par value and equity related transactions	0		0
Stock-based compensation	7,756		1,140			$ 6,616
Stock-based compensation (shares)						212,047		212,047
Dividends paid	(1,853)			(1,853)
Non-controlling interest additions	(61)						(61)
Net income	19,658			19,453			205
Interest rate swaps, net of income taxes	5,869				5,869
Pension and other postretirement benefit plans, net of income taxes	487				487
Repurchase of common stock	(3,903)					$ (3,903)
Repurchase of common stock (shares)						(174,348)		(174,348)
Balance at End of Period at Dec. 31, 2022	$ 188,954	$ 1,194	102,254	85,949	(3,777)	$ (1,362)	4,696
Balance at End of Period (shares) at Dec. 31, 2022		46,699,102				(67,168)		46,631,934
Cash Dividends per Share	$ 0.04
New share issuance	$ 0	$ 2	(2)
New share issuance (shares)		239,455						239,455
Change in par value		$ (727)
Change in par value and equity related transactions	(4,824)		(4,097)
Stock-based compensation	13,971		11,856			$ 2,115
Stock-based compensation (shares)						98,939		98,939
Dividends paid	(1,868)			(1,868)
Non-controlling interest additions	(54)						(54)
Net income	37,025			36,675			350
Interest rate swaps, net of income taxes	(389)				(389)
Pension and other postretirement benefit plans, net of income taxes	(806)				(806)
Repurchase of common stock	(2,202)					$ (2,202)
Repurchase of common stock (shares)						(113,792)		(113,792)
Balance at End of Period at Dec. 31, 2023	$ 229,807	$ 469	110,011	120,756	(4,972)	$ (1,449)	4,992
Balance at End of Period (shares) at Dec. 31, 2023		46,938,557				(82,021)		46,856,536
Cash Dividends per Share	$ 0.04
New share issuance	$ 0	$ 1	(1)
New share issuance (shares)		28,311						28,311
Change in par value		$ 0
Change in par value and equity related transactions	0		0
Stock-based compensation	$ 3,755		(463)			$ 4,218
Stock-based compensation (shares)	228,413					228,413		228,413
Dividends paid	$ (1,876)			(1,876)
Non-controlling interest additions	0						0
Net income	32,153			31,400			753
Interest rate swaps, net of income taxes	(821)				(821)
Pension and other postretirement benefit plans, net of income taxes	24				24
Repurchase of common stock	$ (5,306)					$ (5,306)
Repurchase of common stock (shares)	286,440					(286,440)		(286,440)
Balance at End of Period at Dec. 31, 2024	$ 257,736	$ 470	$ 109,547	$ 150,280	$ (5,769)	$ (2,537)	$ 5,745
Balance at End of Period (shares) at Dec. 31, 2024		46,966,868				(140,048)		46,826,820
Cash Dividends per Share	$ 0.04

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 32,153	$ 37,025	$ 19,658
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	3,755	13,971	7,756
Depreciation and amortization	14,953	15,784	17,161
Assets write-down	1,110	1,143	0
Inventory write-off and obsolescence	2,933	1,719	(142)
Changes in value of life insurance policies	(2,821)	(4,963)	5,069
Deferred income taxes	674	(10,811)	433
Gain on insurance recovery on property, plant and equipment	(4,398)	0	0
Realization of pension obligation	(33)	(892)	451
Net provision for credit losses	1,203	179	(6)
Other non-cash items	(1,020)	406	(405)
Changes in assets and liabilities:
Accounts receivable	(3,612)	(2,618)	(10,078)
Inventories	9,367	(12,976)	(14,860)
Prepaid expenses and other current assets	(5,674)	1,952	(76)
Other assets	(289)	1,509	(1,369)
Accounts payable	519	(12,878)	15,374
Accrued expenses	2,531	(375)	(1,302)
Unearned revenues	4,577	(1,187)	(1,823)
Other liabilities	460	(2,199)	(10,885)
Net cash provided by operating activities	56,388	24,789	24,956
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(13,028)	(10,579)	(10,216)
Patents and other intangibles	20	67	(29)
Proceeds from sale of assets	1,736	485	1,889
Proceeds from sale of business, net of cash sold	0	0	240
Proceeds from insurance recovery	2,102	0	583
Net proceeds on life insurance policies	2,776	3,375	3,677
Net cash used in investing activities	(6,394)	(6,652)	(3,856)
CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of long-term debt	(82,000)	(211,000)	(131,000)
Proceeds from long-term debt	44,000	202,000	116,000
Debt issuance costs	(19)	(1,253)	(2,206)
Equity related transaction costs	(756)	(4,068)	(411)
Dividends paid	(1,876)	(1,868)	(1,853)
Repurchase of common stock	(5,306)	(2,202)	(3,903)
Other financing activities	0	(54)	(2)
Net cash used in financing activities	(45,957)	(18,445)	(23,375)
NET CHANGE IN CASH AND CASH EQUIVALENTS	4,037	(308)	(2,275)
CASH AND CASH EQUIVALENTS, beginning of year	15,120	15,428	17,703
CASH AND CASH EQUIVALENTS, end of year	19,157	15,120	15,428
Supplemental disclosures of cash flow information:
Cash payments for interest	10,859	11,198	9,300
Cash payments for income taxes	17,583	14,535	14,078
Non-cash investing and financing activities:
Capital expenditures incurred but not paid for as of the end of the year	1,670	963	1,157
Equity related transaction costs incurred but not paid for as of the end of the year	$ 0	$ 756	$ 0

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ 31,400	$ 36,675	$ 19,453

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Modified	false
Non-Rule 10b5-1 Arrangement Modified	false
Insider Trading Policies and Procedures Adopted	true

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	3 Months Ended
	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Cybersecurity Risk Management,

Cybersecurity Risk Management, Strategy and Governance	12 Months Ended
	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	ITEM 1C. CYBER SECURITY The Company maintains information systems which contain personal data, financial reports and proprietary data. As a result, we are exposed to cybersecurity threats which could result in loss of or damage to our intellectual property, proprietary information, client data and reputation, or interruption of our business operations, or additional costs to prevent, respond to, or mitigate cyber-attacks. Our Board of Directors is responsible for oversight of the risks that the Company faces, including cybersecurity threats. Our operating divisions and management teams help identify risks that are relevant to the Company during our periodic business planning and review cycle and rank these risks in relation to the achievement of business objectives. We understand cybersecurity threats to be dynamic and to intersect with various other enterprise risks within the organization. We have therefore integrated cybersecurity risk into our overall risk management program. As a result, in addition to our information technology policies and procedures, we have implemented cybersecurity processes that aim to address, among other things, information security, password security, third party vetting, security incident response and vulnerability management. Our cybersecurity procedures include requiring multiple authentication factors prior to granting access to our assets, launching endpoint security software to guard against malware, viruses, and other cyber-attacks, use of third-party software to automate IT system monitoring for unusual or suspicious activity, conducting annual cybersecurity training for all employees, and providing cybersecurity information to employees through newsletters and fliers. We utilize third-party consultants to assist us with endpoint detection and response and routinely conduct penetration testing of our network infrastructure. Our consultants also provide digital forensics analysis of our systems, as needed. Additionally, we have sought to align our cybersecurity risk management in accordance with the National Institute of Standards and Technology Cybersecurity Framework. We recognize that third-party service providers may introduce cybersecurity risks. In an effort to mitigate these risks, we assess third party cybersecurity controls through a cybersecurity questionnaire and include security and privacy addendums to our contracts where applicable. We have established a permanent management position of Director of Cybersecurity and IT Governance that reports directly to the Chief Financial Officer. Our current Director of Cybersecurity and IT Governance, has an undergraduate degree in computer science and is a Certified Information Systems Security Professional. He possesses over 20 years of IT experience with more than 10 years in managerial positions and has been actively involved in IT security related projects, initiatives, audits and associated program management in the last seven years. As part of our cybersecurity incident response plan, we have established a dedicated incident response team to assess and manage risks arising from cybersecurity threats, consisting of our Director of Cybersecurity and IT Governance and various members of senior management, including our Chief Financial Officer and General Counsel. The Company also maintains an IT Steering Committee as part of its control environment, which meets regularly to address matters pertaining to the Company’s information technology systems. The IT Steering Committee is led by the Company’s three IT directors, one of which is the Director of Cybersecurity and IT Governance, and is represented by leaders from corporate departments and operations. In each meeting, the Director of Cybersecurity and IT Governance provides an overview of cybersecurity matters, including status update on threat reduction initiatives undertaken by the Company and future initiatives under consideration. The Audit Committee is responsible for overseeing our cybersecurity threat risks and receives updates during its quarterly meetings from our Director of Cybersecurity and IT Governance. At each meeting, the Audit Committee is briefed on matters pertaining to our exposure to material privacy and cybersecurity risks, as well as risks that are deemed to have a moderate or higher business impact, even if immaterial. The Director of Cybersecurity and IT Governance also routinely briefs senior management on such matters as they arise. In addition, we have established a Data Privacy Committee coordinated by our Data Privacy Officer and represented by seven other committee members from various corporate functional departments. The objective of the Committee is to ensure that personal data is protected and handled in accordance with applicable law and Core Lab policies. As of the date of this Annual Report on Form 10-K, we are not aware of any cybersecurity incident or cybersecurity threat that has materially affected, or is reasonably likely to materially affect, our business strategy, results of operations or financial condition. However, we understand that cybersecurity threats are continually evolving, and the possibility of future discovery of cybersecurity incidents remains. Please see “Item 1A. Risk Factors” for additional information about cybersecurity risks.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	Our Board of Directors is responsible for oversight of the risks that the Company faces, including cybersecurity threats. Our operating divisions and management teams help identify risks that are relevant to the Company during our periodic business planning and review cycle and rank these risks in relation to the achievement of business objectives. We understand cybersecurity threats to be dynamic and to intersect with various other enterprise risks within the organization. We have therefore integrated cybersecurity risk into our overall risk management program.
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	The Audit Committee is responsible for overseeing our cybersecurity threat risks and receives updates during its quarterly meetings from our Director of Cybersecurity and IT Governance. At each meeting, the Audit Committee is briefed on matters pertaining to our exposure to material privacy and cybersecurity risks, as well as risks that are deemed to have a moderate or higher business impact, even if immaterial. The Director of Cybersecurity and IT Governance also routinely briefs senior management on such matters as they arise.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	The Audit Committee is responsible for overseeing our cybersecurity threat risks and receives updates during its quarterly meetings from our Director of Cybersecurity and IT Governance.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	As part of our cybersecurity incident response plan, we have established a dedicated incident response team to assess and manage risks arising from cybersecurity threats, consisting of our Director of Cybersecurity and IT Governance and various members of senior management, including our Chief Financial Officer and General Counsel.
Cybersecurity Risk Role of Management [Text Block]	We have established a permanent management position of Director of Cybersecurity and IT Governance that reports directly to the Chief Financial Officer. Our current Director of Cybersecurity and IT Governance, has an undergraduate degree in computer science and is a Certified Information Systems Security Professional. He possesses over 20 years of IT experience with more than 10 years in managerial positions and has been actively involved in IT security related projects, initiatives, audits and associated program management in the last seven years. As part of our cybersecurity incident response plan, we have established a dedicated incident response team to assess and manage risks arising from cybersecurity threats, consisting of our Director of Cybersecurity and IT Governance and various members of senior management, including our Chief Financial Officer and General Counsel. The Company also maintains an IT Steering Committee as part of its control environment, which meets regularly to address matters pertaining to the Company’s information technology systems. The IT Steering Committee is led by the Company’s three IT directors, one of which is the Director of Cybersecurity and IT Governance, and is represented by leaders from corporate departments and operations. In each meeting, the Director of Cybersecurity and IT Governance provides an overview of cybersecurity matters, including status update on threat reduction initiatives undertaken by the Company and future initiatives under consideration. The Audit Committee is responsible for overseeing our cybersecurity threat risks and receives updates during its quarterly meetings from our Director of Cybersecurity and IT Governance. At each meeting, the Audit Committee is briefed on matters pertaining to our exposure to material privacy and cybersecurity risks, as well as risks that are deemed to have a moderate or higher business impact, even if immaterial. The Director of Cybersecurity and IT Governance also routinely briefs senior management on such matters as they arise. In addition, we have established a Data Privacy Committee coordinated by our Data Privacy Officer and represented by seven other committee members from various corporate functional departments. The objective of the Committee is to ensure that personal data is protected and handled in accordance with applicable law and Core Lab policies.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	Our current Director of Cybersecurity and IT Governance, has an undergraduate degree in computer science and is a Certified Information Systems Security Professional. He possesses over 20 years of IT experience with more than 10 years in managerial positions and has been actively involved in IT security related projects, initiatives, audits and associated program management in the last seven years.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	Our cybersecurity procedures include requiring multiple authentication factors prior to granting access to our assets, launching endpoint security software to guard against malware, viruses, and other cyber-attacks, use of third-party software to automate IT system monitoring for unusual or suspicious activity, conducting annual cybersecurity training for all employees, and providing cybersecurity information to employees through newsletters and fliers.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Description of Business

Description of Business	12 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	1. DESCRIPTION OF BUSINESS Core Laboratories Inc. (“Core Laboratories”, “Core Lab”, “the Company”, “we”, “our” or “us”) is a Delaware corporation. We were established in 1936 and are one of the world’s leading providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry primarily through client relationships with many of the world’s major, national and independent oil companies. These services and products can enable our clients to evaluate and improve reservoir performance and increase oil and gas recovery from their new and existing fields. We make measurements on reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. In addition, we assist clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. We have over 70 offices in more than 50 countries and have approximately 3,500 employees. On May 1, 2023, Core Laboratories N.V. completed its previously announced redomestication transaction (the “Redomestication Transaction”), which through a series of steps, resulted in the merger of Core Laboratories N.V., a holding company in the Netherlands, with and into Core Laboratories Luxembourg S.A., a public limited liability company incorporated under the laws of Luxembourg, with Core Laboratories Luxembourg S.A. surviving, and subsequently the migration of Core Laboratories Luxembourg S.A. out of Luxembourg and its domestication as Core Laboratories Inc., a Delaware corporation. As a result of the Redomestication Transaction, all common shares in Core Laboratories N.V. were canceled and exchanged for common stock in Core Laboratories Luxembourg S.A. on a one-for-one basis. Former holders of Core Laboratories N.V. common shares now hold one share of common stock of Core Laboratories Inc. (formerly Core Laboratories Luxembourg S.A.) for each Core Laboratories N.V. common share owned immediately prior to the consummation of the Redomestication Transaction, and the business, assets, liabilities, directors and officers of Core Laboratories Inc. became the same as the business, assets, liabilities, directors and officers of Core Laboratories N.V. immediately prior to the Redomestication Transaction. We operate our business in two segments: (1) Reservoir Description and (2) Production Enhancement. These complementary operating segments provide different services and products and utilize different technologies for evaluating and improving reservoir performance and increasing oil and gas recovery from new and existing fields. For a description of the types of services and products offered by these operating segments, see Note 21 - Segment Reporting and Other Disaggregated Information .

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation The Redomestication Transaction has been accounted for as a transaction between entities under common control. Accordingly, Core Laboratories Inc. recorded the assets and liabilities transferred at their carrying values at the date of transfer. All common shares in Core Laboratories N.V., at par value EUR 0.02 , were canceled and exchanged for common stock in Core Laboratories Inc., at par value $ 0.01 , on a one-for-one basis. Core Laboratories Inc.’s common stock par value was decreased by $ 0.7 million for the difference between the total par value of common stock of Core Laboratories Inc. and the total par value of common shares of Core Laboratories N.V. at the date of transfer, with an offset to additional paid in capital. There is no difference between the combined separate entities prior to the Redomestication Transaction and the combined separate entities after the Redomestication Transaction, therefore, these financial statements, reported as though the exchange of equity interests had occurred at the beginning of the reporting period, and comparative information do not differ from amounts previously reported under Core Laboratories N.V.’s consolidated financial statements. These financial statements should be read in conjunction with Core Laboratories N.V.’s Quarterly Report on Form 10-Q for the three months ended March 31, 2023 and Core Laboratories N.V.’s Annual Report on Form 10-K for the year ended December 31, 2022, including Note 2 - Summary of Significant Accounting Policies. There have been no changes to the accounting policies of the combined entities during the years ended December 31, 2024 and 202 3. The accompanying consolidated financial statements include the accounts of Core Laboratories Inc. and its subsidiaries for which we have a controlling voting interest and/or a controlling financial interest. These financial statements have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”). We use the equity method of accounting for investments in which we have less than a majority interest and do not exercise control but do exert significant influence. Non-controlling interest has been recorded to reflect outside ownership attributable to consolidated subsidiaries that are less than 100% owned. All inter-company transactions and balances have been eliminated in consolidation. Certain reclassifications were made to prior period amounts in order to conform to the current period presentation. These reclassifications had no impact on the reported net income or cash flows for the years ended December 31, 2023 and 2022. Recent Accounting Pronouncements Pronouncements Adopted in 2024 In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an annual and interim basis. The amendment is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We adopted the guidance for the year ended December 31, 2024 and applied it retrospectively to all prior periods presented in the financial statements. Upon adoption, our disclosures regarding segment reporting was expanded. See Note 21 - Segment Reporting and Other Disaggregated Information. Pronouncements Not Yet Effective In December 2023, FASB issued ASU 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures to improve transparency of income tax disclosures, primarily by requiring consistent categories and greater disaggregation of information in the rate reconciliation and income taxes paid disaggregated by jurisdiction. The amendment is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendment should be applied prospectively; however, retrospective application is permitted. Upon adoption, our disclosures regarding income taxes will be expanded accordingly. In November 2024, FASB issued ASU 2024-03 Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40) to improve disclosures about a public business entity’s expenses, by providing more detailed information about the types of expenses in commonly presented expense captions. As amended by ASU 2025-01 issued in January 2025, the amendment is effective for annual periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendment may be applied prospectively or retrospectively. Upon adoption, our disclosures regarding expenses will be expanded. Use of Estimates The preparation of financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We evaluate our estimates on an ongoing basis and utilize our historical experience, as well as various other assumptions that we believe are reasonable in a given circumstance, in order to make these estimates. Actual results could differ from our estimates, as assumptions and conditions change. The following accounts, among others, require us to use estimates and assumptions: ▪ allowance for credit losses; ▪ obsolete inventory; ▪ depreciation and amortization; ▪ long-lived assets, intangibles and goodwill; ▪ income taxes; ▪ pensions and other postretirement benefits; ▪ stock-based compensation; and ▪ leases. Accounting policies relating to these accounts and the nature of these estimates are further discussed under the applicable caption. For each of these critical estimates it is at least reasonably possible that changes in these estimates will occur in the short term which may impact our financial position or results of operations. Foreign Currencies Our functional currency is the U.S. Dollar (“USD”). All inter-company financing, transactions and cash flows with our subsidiaries are transacted in USD. Revenue and expenses denominated in other currencies are measured at the applicable month-end exchange rate which approximates the average exchange rate. We remeasure monetary assets and liabilities denominated in other currencies to USD at year-end exchange rates. Non-monetary items, depreciation, amortization and certain components of cost of sales are measured at historical rates. Remeasurement and settlement difference are included in other (income) expense, net in the accompanying consolidated statements of operations. See Note 19 - Other (Income) Expense, net . Concentration of Credit Risk Our financial instruments that potentially subject us to concentrations of credit risk relate primarily to cash and cash equivalents and trade accounts receivable. All cash and cash equivalents are on deposit at commercial banks or investment firms with significant financial resources. Our trade receivables are with a variety of domestic, international and national oil and gas companies. We had no clients who provided more than 10% of our revenue for the years ended December 31, 2024, 2023 and 2022 . We consider our credit risk related to trade accounts receivable to be limited due to the creditworthiness and financial resources of our clients. We apply the expected credit losses methodology for measurement of credit losses on financial assets measured at amortized cost basis. We evaluate our estimate for credit losses on an on-going basis throughout the year. Concentration of Interest Rate Risk We are exposed to interest rate risk on our revolving credit facility debt, which carries a variable interest rate. We are exposed to interest rate risk on our Senior Notes which carry a fixed interest rate, but whose fair value will fluctuate based on changes in interest rates and market perception of our credit risk. See Note 11 - Long-term Debt, net . Cash and Cash Equivalents Cash and cash equivalents include all short-term, highly liquid instruments purchased with an original maturity of three months or less. These items are carried at cost, which approximates fair value. Accounts Receivable Trade accounts receivable are recorded at their invoiced amounts and do not bear interest. We perform ongoing credit evaluations of our clients, monitor collections and payments, consider our historical collection experience and our current aging of client receivables outstanding, in addition to client’s representations and our understanding of the economic environment in which our clients operate. Based on our review we establish or adjust allowances for credit losses for specific clients and the accounts receivable, as a whole, and recognize expense. When an account is determined to be uncollectible, we charge the receivable to our allowance for credit losses. The net carrying value of accounts receivable approximates fair value. Contract Assets and Liabilities Contract assets and liabilities arise from differences in timing of revenue recognition, billings and cash collections. Contract assets include our right to payment for goods and services already transferred to a customer when the right to payment is conditional on something other than the passage of time. For example, we have contracts where we recognize revenue over time but do not have a contractual right to payment until we complete the performance obligations. Contract liabilities consist of advance payments received and billings in excess of revenue recognized. We generally receive up-front payments relating to our consortia studies. We recognize revenue over the life of the study as the testing and analysis results are made available to our consortia members. We classify contract liabilities for contracts with a duration greater than twelve months as current or non-current based on the timing of revenue recognition. The current portion of contract liabilities is included in unearned revenues and the non-current portion of contract liabilities is included in other long-term liabilities. Inventories Inventories consist of manufactured goods, materials and supplies used for sales or services to clients. Inventories are stated at the lower of cost or estimated net realizable value. Inventory costs are recorded at standard cost which approximates the first-in, first-out method. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets are comprised primarily of prepaid insurance, value added taxes and prepaid software licenses. Property, Plant and Equipment Property, plant and equipment are carried at cost less accumulated depreciation. Major renewals and improvements are capitalized while maintenance and repair costs are charged to expense as incurred. They are depreciated using the straight-line method based on their individual estimated useful lives, except for leasehold improvements, which are depreciated over the remaining lease term, if shorter. We estimate the useful lives and salvage values of our assets based on historical data as follows: Buildings and leasehold improvements 3 - 40 years Machinery and equipment 3 - 10 years When long-lived assets are sold or retired, the remaining costs and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in income. We review our long-lived assets for impairment when events or changes in circumstances indicate that their net book value may not be recovered over their remaining service lives. Indicators of possible impairment may include significant declines in activity levels in regions where specific assets or groups of assets are located, extended periods of idle use, declining revenue or cash flow or overall changes in general market conditions. Whenever possible impairment is indicated, we compare the carrying value of the assets or asset groups to the sum of the estimated undiscounted future cash flows expected from use, plus salvage value, less the costs of the subsequent disposition of the assets. If impairment is still indicated, we compare the fair value of the assets to the carrying value and recognize an impairment loss for the amount by which the carrying value exceeds the fair value. We did no t record any material impairment charges relating to our long-lived assets held for use during the years ended December 31, 2024, 2023 and 2022. The geopolitical conflict between Russia and Ukraine, which began in February 2022 and has continued through December 31, 2024, has resulted in disruptions to our operations in Russia and Ukraine. The Company evaluated long-lived assets in Russia and Ukraine as part of our assessment of our assets group and did not identify triggering events as of December 31, 2024. Based on our assessments, we determined there was no impairment for long-lived assets in Russia and Ukraine as of December 31, 2024. See Note 18 - Impairments and Other Charges . Leases We have operating leases primarily consisting of offices and lab space, machinery and equipment and vehicles. We determine if an arrangement is an operating or finance lease at inception. Lease assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Where our lease does not provide an implicit rate, we estimate the discount rate used to discount the future minimum lease payments using our incremental borrowing rate and other information available at the commencement date. Operating leased assets also include all initial direct costs incurred. The lease term may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Operating leased assets are included in right of use (“ROU”) assets and, along with current and long-term operating lease liabilities, are separately presented in our consolidated balance sheet. Financing leased assets are included in property, plant and equipment, net and the related liabilities are included in other current and other long- term liabilities in our consolidated balance sheet. ROU assets are subsequently depreciated over the estimated useful life of the asset and lease liabilities are carried at amortized cost using the effective interest rate method. The Company has elected to apply the short-term lease exemption to all classes of underlying ROU assets. Accordingly, no ROU asset or lease liability is recognized for leases with a term of twelve months or less. The Company has elected to apply the practical expedient for combining lease and non-lease components for vehicle leases and elected not to apply the practical expedient for combining lease and non-lease components to all other classes of underlying ROU assets. Intangibles and Goodwill Intangible assets, which include trade secrets, patents, technology, agreements not to compete, trade names, and trademarks, are carried at cost less accumulated amortization, for intangibles with a definite life, and any accumulated impairment. Intangibles with definite lives are amortized using the straight-line method based on the estimated useful life of the intangible. We review our intangible assets with definite lives for impairment when events or changes in circumstances indicate that net book value may not be recovered over their remaining service lives. We record goodwill as the excess of the purchase price over the fair value of the net assets acquired in acquisitions accounted for under the purchase method of accounting. Goodwill is not subject to amortization and is tested for impairment annually or more frequently if events or changes in circumstances indicate goodwill is more likely than not impaired. We assess intangibles with indefinite lives and goodwill for impairment by performing a qualitative assessment or a quantitative test. The qualitative assessment is to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value is less than carrying value. If it is concluded that it is more-likely-than not that an impairment exists, a quantitative test is required which compares the estimated fair value to carrying value. If the estimated fair value is less than carrying value, then there is an impairment loss limited to the carrying value. Significant judgments and assumptions are inherent in our estimate of future cash flows used to determine the estimate of the reporting unit’s fair value which include assumptions regarding future revenue growth rates, discount rates and expected margins. See Note 18 - Impairments and Other Charges . Accounts Payable Trade accounts payable are recorded at their invoiced amounts and do not bear interest. The carrying value of accounts payable approximates fair value. Income Taxes We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statement and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the asset is expected to be recovered or the liability is expected to be settled. We include interest and penalties from tax judgments in income tax expense. We record a liability for unrecognized tax benefits resulting from uncertain tax positions taken or expected to be taken in our tax return. We also recognize interest and penalties, if any, related to unrecognized tax benefits in income tax expense. See Note 9 - Income Taxes. The Company is subject to controlled foreign corporations Subpart F income (“Subpart F”) tax, which is a tax primarily on passive income from controlled foreign corporations. In addition, the 2017 Tax Cuts and Jobs Act imposed a global intangible low-taxed income (“GILTI”) tax that determines the amount of Subpart F income that must be recognized. The FASB Staff Q&A, Topic 740, No. 5, Accounting for Global Intangible Low-Taxed Income, states that an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in the future years or provide for tax expense related to GILTI in the year the tax is incurred. The Company has elected to recognize tax expense related to GILTI in the year the tax is incurred. Pension and Other Postretirement Benefit Plans We provide a non-contributory defined benefit pension plan covering substantially all of our Dutch employees (“Dutch Plan”) who were hired prior to 2000. We recognize net periodic pension costs associated with the Dutch Plan in income and recognize the unfunded status of the plan, if any, as another long-term liability. We recognize the actuarial gains or losses and prior service costs or credits that arise during the period as a component of other comprehensive income. The projection of benefit obligation and fair value of plan assets requires the use of assumptions and estimates. Actual results could differ from those estimates. See Note 12 - Pension and Other Postretirement Benefit Plans . We maintain defined contribution plans for the benefit of eligible employees primarily in Canada, the Netherlands, the United Kingdom and the United States. We expense contributions in the period the contribution is made. Derivative Instruments We may enter into a variety of derivative instruments in connection with the management of our exposure to fluctuations in interest rates or currency exchange rates. See Note 15 - Derivative Instruments and Hedging Activities . We do not enter into derivatives for speculative purposes. Comprehensive Income Comprehensive income is comprised of net income and other charges or credits to equity that are not the result of transactions with owners. Accumulated other comprehensive income (loss) consists of prior service costs and unrecognized net actuarial gain or loss from the Dutch pension plan and changes in the fair value of our interest rate swaps. See Note 12 - Pension and Other Postretirement Benefit Plans and Note 15 - Derivative Instruments and Hedging Activities . Revenue Recognition All of our revenue is derived from contracts with clients. Our contracts include standard commercial payment terms generally acceptable in each region, and do not include financing with extended payment terms. We have no significant obligations for refunds, warranties, or similar obligations. Our revenue does not include taxes collected from our clients. In certain circumstances we apply the guidance in Accounting Standards Codification Topic 606 - Revenue from Contracts with Customers (“Topic 606”) to a portfolio of contracts with similar characteristics. We use estimates and assumptions when accounting for a portfolio that reflect the size and composition of the portfolio of contracts. We recognize revenue at an amount that reflects the consideration expected to be received in exchange for such services or goods as described below by applying the five-step method to: (1) identify the contract(s) with clients; (2) identify the performance obligation(s) in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligation(s) in the contract; and (5) recognize revenue when (or as) we satisfy the performance obligation(s). A performance obligation is a promise in a contract to transfer a distinct service or good to a client and is the unit of account under Topic 606. We have contracts with two general groups of performance obligations: those that require us to perform analysis and/or diagnostic tests in our laboratory or at the client’s wellsite and those from the sale of tools, diagnostic and equipment products and related services. Service Revenue : We provide a variety of services to clients in the oil and gas industry. Where services are provided related to the testing and analysis of rock and fluids, we recognize revenue upon the provision of the test results or analysis to the client. For our design, field engineering and completion diagnostic services, we recognize revenue upon the delivery of those services at the well site or delivery of diagnostic data. In the case of our consortia studies, we have multiple performance obligations and revenue is recognized at the point in time when the testing and analysis results on each contributed core are made available to our consortia members. For arrangements that include multiple performance obligations, we allocate revenue to each performance obligation based on estimates of the price that we would charge the client for each promised service or product if it were sold on a standalone basis. To a lesser extent, we enter into other types of contracts including service arrangements and non-subscription software and licensing agreements. We recognize revenue for these arrangements over time or at a point in time depending on our evaluation of when the client obtains control of the promised services or products. Product Sales Revenue : We manufacture equipment that we sell to our clients in the oil and gas industry. We recognize revenue when control of the promised product is transferred to the client. Control of the product usually passes to the client at the time shipment is made or picked up by the client at our facilities, as defined within the contract. Disaggregation of Revenue We contract with clients for service revenue and/or product sales revenue. We present revenue disaggregated by services and product sales in our consolidated statements of operations. For revenue disaggregated by operating segment, see Note 21 - Segment Reporting and Other Disaggregated Information . Stock-Based Compensation For new awards issued and awards modified, repurchased or canceled, we record compensation expense in the consolidated statements of operations equal to the fair value of the award at the date of the grant, modification, repurchase or cancellation over the requisite service period of the award. The fair value is generally determined by the quoted market price of the Company’s common stock on the date of grant less the discounted value of the expected dividends to be paid over the vesting period. Market vesting conditions, as applicable, are included in the estimation of the fair value of the award. Forfeitures are recognized as they occur. Non-controlling Interests We maintain non-controlling interests in several investment ventures. Non-controlling interest have been recorded to reflect outside ownership attributable to consolidated subsidiaries that are less than 100% owned and presented as a separate component of equity in the consolidated balance sheets and income in the consolidated statements of operations and other comprehensive income, respectively. In addition, when a subsidiary is deconsolidated, any retained non-controlling equity investment in the former subsidiary will be initially measured at fair value and recorded as a gain or loss.

Acquisitions and Divestures

Acquisitions and Divestures	12 Months Ended
	Dec. 31, 2024
Business Combinations [Abstract]
Acquisitions and Divestures	3. ACQUISITIONS AND DIVESTURES We had no significant acquisitions or divestitures during the years ended December 31, 2024, 2023 and 2022 .

Contract Assets and Liabilities

Contract Assets and Liabilities	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Contract Assets and Liabilities	4. CONTRACT ASSETS AND LIABILITIES The balance of contract assets and contract liabilities consist of the following (in thousands): December 31, 2024 2023 Contract assets: Current $ 370 $ 1,293 $ 370 $ 1,293 Contract liabilities: Current $ 560 $ 299 $ 560 $ 299 December 31, 2024 Estimate of when contract liabilities will be recognized as revenue: Within 12 months $ 560 The current portion of contract assets is included in our accounts receivable as of December 31, 2024 and 2023. The current portion of contract liabilities is included in unearned revenues as of December 31, 2024 and 2023 and, as applicable, the non-current portion of contract liabilities is included in other long-term liabilities. We did no t recognize any impairment losses on our contract assets for the years ended December 31, 2024, 2023 and 2022 .

Inventories

Inventories	12 Months Ended
	Dec. 31, 2024
Inventory Disclosure [Abstract]
Inventories	5. INVENTORIES Inventories consist of the following (in thousands): December 31, 2024 2023 Finished goods $ 27,127 $ 30,508 Parts and materials 28,953 37,670 Work in progress 3,322 3,524 Total inventories $ 59,402 $ 71,702 We include freight costs incurred for shipping inventory to our clients in the cost of product sales caption in the accompanying consolidated statements of operations.

Property, Plant, and Equipment,

Property, Plant, and Equipment, Net	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Net	6. PROPERTY, PLANT AND EQUIPMENT, NET The components of property, plant and equipment, net are as follows (in thousands): December 31, 2024 2023 Land $ 10,402 $ 10,652 Building and leasehold improvements 117,682 120,545 Machinery and equipment 283,296 284,225 Total property, plant and equipment 411,380 415,422 Less: Accumulated depreciation ( 314,317 ) ( 315,796 ) Property, plant and equipment, net $ 97,063 $ 99,626 See Note 19 - Other (Income) Expense, net for additional information regarding the write-down of leasehold improvements.

Leases

Leases	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Leases	7. LEASES Our operating leases primarily consist of offices and lab space, machinery and equipment and vehicles. We abandoned certain leases in the U.S. and Canada during the years ended December 31, 2024 and 2023. We entered into a sublease agreement that commenced on July 1, 2023, for a portion of the existing office and lab space in Calgary, Alberta, Canada. See Note 19 - Other (Income) Expense, net for additional information regarding the write-down of right of use assets. The components of lease expense and other information are as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 Consolidated Statements of Operations: Operating lease expense $ 16,998 $ 17,454 $ 16,595 Short-term lease expense 1,720 1,768 1,784 Variable lease expense 1,719 1,758 1,414 Sublease income ( 227 ) ( 113 ) — Total lease expense $ 20,210 $ 20,867 $ 19,793 Consolidated Statements of Cash Flows: Operating cash flows - operating leases payments $ 16,708 $ 16,541 $ 16,598 Right of use assets obtained in exchange for operating lease liabilities $ 14,237 $ 17,005 $ 5,520 Other information: Weighted-average remaining lease term - operating leases 8.70 years 9.24 years 6.88 years Weighted-average discount rate - operating leases 5.45 % 5.32 % 4.62 % Scheduled undiscounted lease payments for non-cancellable operating leases consist of the following (in thousands): December 31, 2024 Operating Leases Operating Sublease 2025 $ 13,245 $ ( 231 ) 2026 10,417 ( 236 ) 2027 8,324 ( 241 ) 2028 6,586 ( 163 ) 2029 4,388 — Thereafter 25,505 — Total undiscounted lease payments 68,465 $ ( 871 ) Less: Imputed interest ( 14,432 ) Total operating lease liabilities $ 54,033

Intangibles and Goodwill

Intangibles and Goodwill	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangibles and Goodwill	8. INTANGIBLES AND GOODWILL The components of intangibles, net are as follows (in thousands): December 31, 2024 2023 Gross Accumulated Amortization Gross Accumulated Amortization Useful life in years Carrying Value and Impairment Carrying Value and Impairment Acquired trade secrets 2 - 20 $ 4,278 $ 3,967 $ 4,278 $ 3,756 Acquired patents and technology 4 - 15 15,722 14,243 15,744 13,953 Agreements not to compete 2 - 5 1,105 1,105 1,105 1,105 Acquired trade names and trademarks Indefinite 4,624 11 4,624 11 Total intangibles, net $ 25,729 $ 19,326 $ 25,751 $ 18,825 Our estimated amortization expense relating to these intangibles for the next five years is summarized in the following table (in thousands): December 31, 2024 2025 $ 359 2026 $ 231 2027 $ 193 2028 $ 98 2029 $ 35 The carrying value of goodwill of $ 99.4 million as of December 31, 2024 and 2023 is associated with our Reservoir Description operating segment. There have been no changes in the carrying value during the years ended December 31, 2024, 2023 and 2022.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	9. INCOME TAXES The components of income before income taxes are as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 United States $ ( 11,045 ) $ 3,907 $ ( 4,099 ) Other countries 57,232 37,303 34,053 Income before income taxes $ 46,187 $ 41,210 $ 29,954 The components of income tax expense are as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 Current: United States $ 1,231 $ 1,204 $ 1,269 Other countries 12,205 13,446 9,784 State and provincial ( 22 ) 597 ( 100 ) Total current 13,414 15,247 10,953 Deferred: United States ( 2,487 ) 1,555 ( 908 ) Other countries 2,842 ( 12,343 ) ( 162 ) State and provincial 265 ( 274 ) 413 Total deferred 620 ( 11,062 ) ( 657 ) Income tax expense $ 14,034 $ 4,185 $ 10,296 The differences in income tax expense computed using the statutory income tax rate and our income tax expense as reported in the accompanying consolidated statements of operations are as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 Tax at the statutory income tax rate (1) $ 9,553 $ 8,139 $ 7,368 International earnings taxed at rates other than the statutory income tax rate (1) 2,237 5,749 5,923 Non-deductible expenses 1,092 2,168 3,096 Net operating loss ( 190 ) 4,661 ( 3,627 ) Foreign earnings currently taxed in the U.S. 3,934 3,077 — Change in valuation allowance 337 ( 1,107 ) 1,943 State and provincial taxes 136 243 662 Tax credits ( 5,823 ) ( 7,410 ) ( 6,872 ) Unremitted earnings of subsidiaries 891 ( 14,464 ) ( 27 ) Adjustments of prior year taxes ( 935 ) 701 ( 3,488 ) Adjustments of income tax reserves 208 519 ( 184 ) Foreign exchange ( 964 ) ( 171 ) ( 576 ) UK tax rate change — — 676 Accrued withholding taxes 3,262 1,639 1,883 Other 296 441 3,519 Income tax expense $ 14,034 $ 4,185 $ 10,296 (1) Based on the U.S. statutory corporate income tax rate of 21 % for 2024 and 2023 and the Netherlands statutory income tax rate of 25 % for 2022. Deferred tax assets and liabilities result from various temporary differences between the financial statement carrying value and their tax basis. Deferred tax assets and liabilities are summarized as follows (in thousands): December 31, 2024 2023 Deferred tax assets: Net operating loss carry-forwards $ 6,279 $ 7,814 Tax credit carry-forwards 5,811 2,144 Accruals for compensation 9,236 8,985 Accruals for inventory capitalization 1,673 1,621 Unrealized benefit from corporate restructuring 36,762 40,963 Intangibles 1,886 1,584 Unrealized benefit plan loss 962 1,224 Unrealized foreign exchange 2,819 2,875 Unearned revenue 2,632 3,453 Interest carry-forward 11,367 7,912 Other 1,074 1,401 Total deferred tax assets 80,501 79,976 Valuation allowance ( 8,812 ) ( 8,276 ) Net deferred tax assets 71,689 71,700 Deferred tax liabilities: Property, plant and equipment, net ( 2,840 ) ( 3,566 ) Accrued withholding taxes ( 11,279 ) ( 10,466 ) Unrealized foreign exchange ( 1,542 ) ( 988 ) Other ( 198 ) ( 176 ) Total deferred tax liabilities ( 15,859 ) ( 15,196 ) Net deferred income taxes $ 55,830 $ 56,504 The table below summarizes the net deferred tax assets and net deferred tax liabilities by legal jurisdiction (in thousands): December 31, 2024 2023 Long-term deferred tax assets, net $ 69,613 $ 69,201 Long-term deferred tax liabilities, net ( 13,783 ) ( 12,697 ) Net deferred income taxes $ 55,830 $ 56,504 At December 31, 2024 , we had tax net operating loss carry-forwards in various tax jurisdictions of $ 28.8 million. Although we cannot be certain that these operating loss carry-forwards will be utilized, we anticipate that we will have sufficient taxable income in future years to allow us to fully utilize the carry-forwards that are not subject to a valuation allowance. As of December 31, 2024 , if unused, $ 0.8 million will expire between 2025 and 2026, $ 2.9 million will expire between 2027 and 2029, $ 3.2 million will expire between 2030 and 2033 and $ 1.4 million will expire beyond 2033. The remaining balance of $ 20.5 million is not subject to expiration. During 2024 , no material net operating loss carry-forwards, which carried a full valuation allowance, expired unused. We file income tax returns in the U.S. federal jurisdiction, various states and foreign jurisdictions. We are currently undergoing multiple examinations in various jurisdictions, and the years 2011 through 2023 remain open for examination in various tax jurisdictions in which we operate. The ultimate settlement and timing of these additional tax assessments is uncertain but the Company will continue to vigorously defend its return filing position and does not view the assessments as probable at this time. The Company is subject to controlled foreign corporations Subpart F income (“Subpart F”) tax, which is a tax primarily on passive income from controlled foreign corporations. In addition, the 2017 Tax Cuts and Jobs Act imposed a global intangible low-taxed income (“GILTI”) tax that determines the amount of Subpart F income that must be recognized. The Company estimates approximately $ 10.0 million of GILTI income and $ 8.7 million of Subpart F income for the year ended December 31, 2024 with a U.S. tax effect of $ 2.1 million and $ 1.8 million, respectively. For the year ended December 31, 2023, the company estimated no GILTI income and Subpart F income of $ 14.7 million with a U.S. tax effect of $ 3.1 million. During 2024 , adjustments were made to estimates for uncertain tax positions in certain tax jurisdictions based upon changes in facts and circumstances, resulting in a reduction to the unrecognized tax benefits. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 Unrecognized tax benefits at January 1, $ 3,483 $ 3,509 $ 4,327 Tax positions, current period 138 144 230 Tax positions, prior period ( 165 ) 68 ( 867 ) Settlements with taxing authorities — — ( 19 ) Lapse of applicable statute of limitations ( 184 ) ( 238 ) ( 162 ) Unrecognized tax benefits at December 31, $ 3,272 $ 3,483 $ 3,509 Our policy is to record accrued interest and penalties on uncertain tax positions, net of any tax effect, as part of total tax expense for the period. The corresponding liability is carried along with the tax exposure as a non-current payable in other long-term liabilities. For the years ended December 31, 2024, 2023 and 2022 , we recognized $ 0.2 million, $ 0.6 million and $( 0.2 ) million, respectively, in interest and penalties. As of December 31, 2024 and 2023 , we had $ 5.1 million and $ 4.9 million, respectively, accrued for the payment of interest and penalties. Changes in our estimate of unrecognized tax benefits would affect our effective tax rate. As of December 31, 2024 , there are $ 0.4 million of unrecognized tax benefits that could be resolved within the next twelve months which could have a positive effect on the annual effective tax rate.

Other Assets

Other Assets	12 Months Ended
	Dec. 31, 2024
Table Text Block Supplement [Abstract]
Other Assets	10. OTHER ASSETS Other assets consist of the following (in thousands): December 31, 2024 2023 Cash surrender value of life insurance policies $ 25,435 $ 25,397 Investments in unconsolidated affiliates 5,080 4,844 Other 4,273 3,978 Total other assets $ 34,788 $ 34,219 Cash surrender value of life insurance policies relates to postretirement benefit plans. See Note 12 - Pension and Other Postretirement Benefit Plans . Investments include unconsolidated affiliates accounted for under the equity method where the operations of these entities are in-line with those of our core business. These entities are not considered special purpose entities, nor do we have special off-balance sheet arrangements through these entities.

Long-Term Debt, Net

Long-Term Debt, Net	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Long-Term Debt, Net	11. LONG-TERM DEBT, NET We have no finance lease obligations. Debt is summarized in the following table (in thousands): December 31, Interest Rate Maturity Date 2024 2023 2021 Senior Notes Series A (1) 4.09 % January 12, 2026 $ 45,000 $ 45,000 2021 Senior Notes Series B (1) 4.38 % January 12, 2028 15,000 15,000 2023 Senior Notes Series A (2) 7.25 % June 28, 2028 25,000 25,000 2023 Senior Notes Series B (2) 7.50 % June 28, 2030 25,000 25,000 Credit Facility 18,000 56,000 Total long-term debt 128,000 166,000 Less: Debt issuance costs ( 1,889 ) ( 2,866 ) Long-term debt, net $ 126,111 $ 163,134 (1) Interest is payable semi-annually on June 30 and December 30. (2) Interest is payable semi-annually on March 28 and September 28. We, along with our wholly owned subsidiary Core Laboratories (U.S.) Interests Holdings, Inc. (“CLIH”) as issuer, have senior notes outstanding that were issued through private placement transactions. As of December 31, 2024, we have two series of senior notes outstanding with an aggregate principal amount of $ 110.0 million: (1) Series A and Series B of the 2021 Senior Notes were issued in 2021 (the “2021 Senior Notes”), and (2) Series A and Series B of the 2023 Senior Notes were issued on June 28, 2023 (the “2023 Senior Notes”). The 2021 Senior Notes and the 2023 Senior Notes are collectively the “Senior Notes”. We, along with CLIH, have a credit facility, the Eighth Amended and Restated Credit Agreement (as amended, the “Credit Facility”) for an aggregate borrowing commitment of $ 135.0 million with a $ 50.0 million “accordion” feature. The Credit Facility is secured by first priority interests in (1) substantially all of the tangible and intangible personal property, and equity interest of CLIH and certain of the Company’s U.S. and foreign subsidiary companies; and (2) instruments evidencing intercompany indebtedness owing to the Company, CLIH and certain of the Company’s U.S. and foreign subsidiary companies. Under the Credit Facility, the Secured Overnight Financing Rate (“SOFR”) plus 2.00 % to SOFR plus 3.00 % will be applied to outstanding borrowings. Any outstanding balance under the Credit Facility is due at maturity on July 25, 2026 , subject to springing maturity on July 12, 2025, if any portion of the Company’s 2021 Senior Notes Series A due January 12, 2026, in the aggregate principal amount of $ 45.0 million, remain outstanding on July 12, 2025, unless the Company’s liquidity equals or exceeds the principal amount of the 2021 Senior Notes Series A outstanding on such date. The available capacity at any point in time is reduced by outstanding borrowings and outstanding letters of credit which totaled approximately $ 10.8 million at December 31, 2024 , resulting in an available borrowing capacity under the Credit Facility of approximately $ 106.1 million. In addition to indebtedness under the Credit Facility, we had approximately $ 7.6 million of outstanding letters of credit and performance guarantees and bonds from other sources as of December 31, 2024. The Credit Facility and Senior Notes include a cross-default provision, whereby a default under one agreement may trigger a default in the other agreements. The terms of the Credit Facility and Senior Notes require us to meet certain covenants, including, but not limited to, an interest coverage ratio (calculated as consolidated EBITDA divided by interest expense) and a leverage ratio (calculated as consolidated net indebtedness divided by consolidated EBITDA), where consolidated EBITDA (as defined in each agreement) and interest expense are calculated using the most recent four fiscal quarters. The Credit Facility has more restrictive covenants with a minimum interest coverage ratio of 3.00 to 1.00 and permits a maximum leverage ratio of 2.50 to 1.00 . The Credit Facility allows non-cash charges such as impairment of assets, stock compensation and other non-cash charges to be added back in the calculation of consolidated EBITDA. The terms of our Credit Facility also allow us to negotiate in good faith to amend any ratio or requirement to preserve the original intent of the agreement if any change in accounting principles would affect the computation of any financial ratio or covenant of the Credit Facility. In accordance with the terms of the Credit Facility, our leverage ratio is 1.31 , and our interest coverage ratio is 6.74 , each for the period ended December 31, 2024. We are in compliance with all covenants contained in our Credit Facility and Senior Notes as of December 31, 2024. Certain of our material, wholly owned subsidiaries are guarantors or co-borrowers under the Credit Facility and Senior Notes. See Note 15 - Derivative Instruments and Hedging Activities for additional information regarding interest rate swap agreements we have entered to fix the underlying risk-free rate on our Credit Facility and Senior Notes. The estimated fair value of total debt at December 31, 2024 and 2023 approximated the book value of total debt. The fair value was estimated using Level 2 inputs by calculating the sum of the discounted future interest and principal payments through the maturity date.

Pension and Other Postretiremen

Pension and Other Postretirement Benefit Plans	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Pension and Other Postretirement Benefit Plans	12. PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS Defined Benefit Plan Prior to January 2020, one of our subsidiaries provided a noncontributory defined benefit pension plan covering substantially all of our Dutch employees who were hired prior to 2000. This pension benefit was based on years of service and final pay or career average pay depending on when the employee began participating. The Dutch Plan was curtailed prior to January 2020, and these employees have been moved into the Dutch defined contribution plan. However, the unconditional indexation for this group of participants continues for so long as they remain in active service with the Company. The following table summarizes the change in the projected benefit obligation and the fair value of plan assets for the Dutch Plan (in thousands): For the Years Ended December 31, 2024 2023 Projected Benefit Obligation: Projected benefit obligation at beginning of year $ 43,985 $ 40,059 Interest cost 1,403 1,480 Benefits paid and administrative expenses ( 1,587 ) ( 1,505 ) Actuarial (gain) loss, net ( 1,114 ) 2,905 Unrealized (gain) loss on foreign exchange ( 2,018 ) 1,046 Projected benefit obligation at end of year $ 40,669 $ 43,985 Fair Value of Plan Assets: Fair value of plan assets at beginning of year $ 41,713 $ 37,376 Increase (decrease) in plan asset value 12 3,137 Employer contributions 742 1,719 Benefits paid and administrative expenses ( 1,587 ) ( 1,505 ) Unrealized gain (loss) on foreign exchange ( 1,931 ) 986 Fair value of plan assets at end of year $ 38,949 $ 41,713 Under-funded status of the plan at end of the year $ ( 1,720 ) $ ( 2,272 ) Accumulated Benefit Obligation $ 40,669 $ 41,727 The following actuarial assumptions were used to determine the actuarial present value of our projected benefit obligation and the net periodic pension cost for the Dutch Plan: For the Years Ended December 31, 2024 2023 Weighted average assumed discount rate 3.48 % 3.27 % Expected long-term rate of return on plan assets 3.48 % 3.27 % Weighted average rate of compensation increase 2.00 % 2.10 % The discount rate used to determine our projected benefit obligation at December 31, 2024 was increased from 3.27 % to 3.48 %, consistent with a general increase in interest rates in Europe for AAA-rated long-term Euro government bonds. Amounts recognized for the Dutch Plan in the consolidated balance sheets consist of (in thousands): December 31, 2024 2023 Deferred tax asset $ 440 $ 582 Other long-term liabilities 1,720 2,272 Accumulated other comprehensive loss ( 5,890 ) ( 5,914 ) The components of net periodic pension cost for the Dutch Plan include (in thousands): For the Years Ended December 31, 2024 2023 2022 Interest cost $ 1,403 $ 1,480 $ 581 Expected return on plan assets ( 1,178 ) ( 1,365 ) ( 545 ) Net periodic pension cost $ 225 $ 115 $ 36 We funded the future obligations of the Dutch Plan by purchasing an insurance contract from a large multi-national insurance company with a five-year maturity. Each year we made annual premium payments to the insurance company (1) to provide for the benefit obligation of the current year of service based on each employee’s age, gender and current salary, and (2) for the changes in the benefit obligation for prior years of service due to changes in participants’ salary. Plan assets returns equal the contractual rate, which are comparable with governmental debt securities. We determine the fair value of these plan assets with the assistance of an actuary using observable inputs (Level 2), which approximates the contract value of the investments. Our expected long-term rate of return assumptions are based on the weighted-average contractual rates for each contract. Dutch law dictates the minimum requirements for pension funding. Our goal is to meet these minimum funding requirements, while our insurance carrier invests to minimize risks associated with future benefit payments. In 2025 , our minimum funding requirements are expected to be $ 0.3 million. Our estimate of future annual contributions is based on current funding and the unconditional indexation requirements, and we believe these contributions will be sufficient to fund the plan. Expected benefit payments to eligible participants under this plan for the next five years are as follows (in thousands): December 31, 2024 2025 $ 1,580 2026 $ 1,752 2027 $ 1,941 2028 $ 2,065 2029 $ 2,224 Succeeding five years $ 11,833 Defined Contribution Plans We maintain defined contribution plans for the benefit of eligible employees primarily in Canada, the Netherlands, the United Kingdom, and the United States. In accordance with the terms of each plan, we and our participating employees contribute up to specified limits and under certain plans, we may make discretionary contributions in accordance with the defined contribution plans. Our primary obligation under these defined contribution plans is limited to paying the annual contributions. For the years ended December 31, 2024, 2023 and 2022 , we paid $ 4.7 million, $ 4.3 million and $ 3.5 million, respectively, for our contributions and our additional discretionary contributions to the defined contribution plans. Vesting in all employer contributions is accelerated upon the death of the participant or a change in control. Employer contributions under the plans are forfeited upon a participant’s termination of employment to the extent they are not vested at that time. Deferred Compensation Arrangements We have entered into deferred compensation contracts for certain key employees to provide additional retirement income to the participants. The benefit is determined by the contract for either a fixed amount or by a calculation using years of service or age at retirement along with the average of their base salary for the five years prior to retirement. We are not required to fund this arrangement; however, we have purchased life insurance policies with cash surrender values to assist us in providing the benefits pursuant to these deferred compensation contracts with the actual benefit payments made by Core Laboratories. The charge to expense for these deferred compensation contracts for the years ended December 31, 2024, 2023 and 2022 was $ 0.9 million, $ 1.1 million and $ 1.4 million, respectively. We provide severance compensation to certain key employees if employment is terminated under certain circumstances, such as following a change in control or for any reason other than upon their death or disability, for “cause” or upon a material breach of a material provision of their employment agreement, as defined in their employment agreements. In addition, there are certain countries where we are legally required to make severance payments to employees when they leave our service. We have accrued for all of these severance payments, but they are not funded. We also have adopted a non-qualified deferred compensation plan (“Deferred Compensation Plan”) that allows certain highly compensated employees to defer a portion of their salary, commission and bonus, as well as the amount of any reductions in their deferrals under the Deferred Compensation Plan for employees in the United States, due to certain limitations imposed by the U.S. Internal Revenue Code of 1986, as amended (the “Code”). Contributions to the plan are invested in equity and other investment fund assets and carried on the balance sheet at fair value. The benefits under these contracts are fully vested. Our primary obligation for the Deferred Compensation Plan is limited to our annual contributions. Employer contributions to the Deferred Compensation Plan for the years ended December 31, 2024, 2023 and 2022 were $ 0.4 million, $ 0.4 million and $ 0.3 million, respectively. Vesting in all employer contributions is accelerated upon the death of the participant or a change in control. Employer contributions under the plans are forfeited upon a participant’s termination of employment to the extent they are not vested at that time.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	13. COMMITMENTS AND CONTINGENCIES We have been and may from time to time be named as a defendant in legal actions that arise in the ordinary course of business. These include, but are not limited to, employment-related claims and contractual disputes or claims for personal injury or property damage which occur in connection with the provision of our services and products. A liability is accrued when a loss is both probable and can be reasonably estimated. We do not maintain any off-balance sheet debt or other similar financing arrangements, nor have we formed any special purpose entities for the purpose of maintaining off-balance sheet debt. See Note 11 - Long-term Debt, net for amounts committed under letters of credit and performance guarantees and bonds.

Equity

Equity	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Equity	14. EQUITY Common Stock In connection with the Redomestication Transaction in May 2023, all common shares in Core Laboratories N.V. at par value EUR 0.02 , were canceled and exchanged for common stock in Core Laboratories Inc. at par value $ 0.01 , on a one-for-one basis. Core Laboratories Inc.’s common stock par value was decreased by $ 0.7 million for the difference between the total par value of common stock of Core Laboratories Inc. and the total par value of common shares of Core Laboratories N.V. at the date of transfer, with an offset to additional paid in capital. Equity related transaction costs associated with the Redomestication Transaction of $ 4.8 million have been charged to additional paid in capital. In addition, Core Laboratories N.V. assigned to Core Laboratories Inc., and Core Laboratories Inc. assumed, all of Core Laboratories N.V.’s rights and obligations under stock incentive plans. Each outstanding Core Laboratories N.V. incentive award thereunder became a Core Laboratories Inc. incentive award that is subject to substantially the same terms and conditions as the former Core Laboratories N.V. incentive award, except, in the case of equity-based Core Laboratories N.V. incentive awards, the security issuable upon exercise or settlement of the incentive award, as applicable, will be a share of Core Laboratories Inc. common stock rather than a Core Laboratories N.V. common share. During the year ended December 31, 2024 , we distributed 28,311 shares of common stock upon vesting of stock-based awards. On June 9, 2022, we entered into an Equity Distribution Agreement with certain banks (the “2022 Equity Distribution Agreement”) allowing for the issuance and sale of up to $ 60.0 million shares of our common stock by any method deemed to be an “at-the-market offering” as defined in Rule 415 under the Securities Act of 1933 (the “2022 ATM Program”). On July 17, 2023, the Company terminated the 2022 Equity Distribution Agreement. As a result of the termination of the 2022 Equity Distribution Agreement, the Company suspended and terminated the 2022 ATM Program and therefore will not offer or sell any shares under the 2022 ATM Program or the 2022 Equity Distribution Agreement. Treasury Stock The repurchase of shares in the open market is at the discretion of our Board of Directors and management. Such common stock, unless canceled, may be reissued for a variety of purposes such as future acquisitions, non-employee director stock awards or employee stock awards. From the activation of the share repurchase program on October 29, 2002 through December 31, 2024 , we have repurchased 40,666,075 shares for an aggregate purchase price of approximately $ 1.7 billion, or an average price of $ 41.12 per share and have canceled 33,475,406 shares with a historical cost of $ 1.2 billion. At December 31, 2024 , we held 140,048 shares in treasury. During the year ended December 31, 2024 , we distributed 228,413 shares of treasury stock upon vesting of stock-based awards. During the year ended December 31, 2024 , we repurchased 286,440 shares of our common stock for $ 5.3 million, of which 109,224 shares valued at $ 2.0 million were surrendered to us pursuant to the terms of a stock-based comp ensation plan in consideration of the participants’ tax burdens resulting from the issuance of common stock under that plan. Subsequent to year-end, we have repurchased 228 shares of our common stock for approximately $ 4.0 thousand. Dividend Policy In 2008, Core Laboratories announced the initiation of a cash dividend program. In 2024, 2023 and 2022 , cash dividends of $ 0.01 per share were paid in each quarter. The declaration and payment of future dividends will be at the discretion of the Board of Directors and will depend upon, among other things, future earnings, general financial condition, liquidity, capital requirements, and general business conditions. On January 29, 2025 , the Company declared a quarterly cash dividend of $ 0.01 per share for shareholders of record on February 10, 2025 payable on March 3, 2025 . Accumulated Other Comprehensive Income (Loss) Amounts recognized, net of income taxes, in accumulated other comprehensive income (loss) consist of the following (in thousands): December 31, 2024 2023 Pension and other postretirement benefit plans - unrecognized prior service costs and net actuarial loss $ ( 5,890 ) $ ( 5,914 ) Interest rate swaps - net fair value gain 121 942 Total accumulated other comprehensive income (loss) $ ( 5,769 ) $ ( 4,972 )

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities	15. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES We are exposed to market risks related to fluctuations in interest rates. To mitigate these risks, we utilize derivative instruments in the form of interest rate swaps. We do not enter into derivative transactions for speculative purposes. Under the Company’s Credit Facility, the SOFR plus 2.00 % to SOFR plus 3.00 % will be applied to outstanding borrowings. See Note 11 - Long-term Debt, net for additional information. The Company has elected to apply the optional expedient for hedging relationships affected by reference rate reform. Accordingly, no outstanding balance on the Credit Facility with a SOFR rate will preclude cash flow hedging with existing London Inter-Bank Offer Rate (“LIBOR”) hedging instruments. In August 2014, we entered into a swap agreement, that would have expired August 29, 2024 , with a notional amount of $ 25 million (“2014 Variable-to-Fixed Swap”), and the LIBOR portion of the interest rate was fixed at 2.5 %. In February 2020, we entered into a second swap agreement with a notional amount of $ 25 million (“2020 Variable-to-Fixed Swap”), and the LIBOR portion of the interest rate was fixed at 1.3 % through February 28, 2025 . These interest rate swap agreements were terminated, dedesignated and settled in March 2021. The hedging relationship is highly effective; therefore, gains and losses on these swaps are reclassified into interest expense in accordance with the forecasted transactions or the scheduled interest payments on the Credit Facility. The 2014 Variable-to-Fixed Swap was fully amortized during the year ended December 31, 2024. The remaining net gain on the 2020 Variable-to-Fixed Swap included in accumulated other comprehensive income (loss) at December 31, 2024, is nominal, and will be reclassified into earnings as interest payments are made on the Company’s Credit Facility through February 2025. In March 2021, we entered into a new forward interest rate swap agreement and carried the fair value of the terminated 2014 and 2020 Variable-to-Fixed Swaps into the new agreement in a “blend and extend” structured transaction. The purpose of this forward interest rate swap agreement is to fix the underlying risk-free rate, that would be associated with the anticipated issuance of new long-term debt by the Company in future periods. The forward interest rate swap would hedge the risk-free rate on forecasted long-term debt for a maximum of 11 years through March 2033. Risk associated with future changes in the 10-year LIBOR interest rates have been fixed up to a notional amount of $ 60 million with this instrument. The interest rate swap qualifies as a cash flow hedging instrument . The forward interest rate swap agreement was terminated and settled in April 2022. The hedging relationship is highly effective, therefore, the gain on the termination of the forward interest rate swap was included in accumulated other comprehensive income (loss). I n June 2023, the Company issued the 2023 Senior Notes with an aggregate principal amount of $ 50 million at fixed interest rates of 7.25 % and 7.50 %. The Company has elected to apply the optional expedient for hedging relationships affected by reference rate reform. Accordingly, no outstanding balance on the 2023 Senior Notes will preclude cash flow hedging with the existing LIBOR hedging instrument. The Company recognized a gain of $ 0.4 million in earnings for the $ 10 million over hedged portion of the interest rate swap in 2023. A net gain of $ 0.1 million is included in accumulated other comprehensive income (loss) at December 31, 2024. The unamortized balance on this swap will be amortized into interest expense in accordance with the forecasted transactions or the scheduled interest payments on the 2023 Senior Notes and any future debt through March 203 3. As of December 31, 2024 , the aggregated gains and losses on these interest swaps that are included in accumulated other comprehensive income (loss) are a net gain of $ 0.1 million. As of December 31, 2024 , we had fixed rate long-term debt aggregating $ 110 million and variable rate long-term debt aggregating $ 18 million. The effect of the interest rate swaps on the consolidated statements of operations was as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 Income Statement Classification Derivatives designated as hedges: 5 year interest rate swap $ 57 $ 260 $ 343 Increase (decrease) to interest expense 10 year interest rate swap ( 1,097 ) ( 752 ) 655 Increase (decrease) to interest expense $ ( 1,040 ) $ ( 492 ) $ 998

Financial Instruments

Financial Instruments	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Financial Instruments	16. FINANCIAL INSTRUMENTS The Company’s only financial assets and liabilities which are measured at fair value on a recurring basis relate to certain aspects of the Company’s benefit plans. We use the market approach to determine the fair value of these assets and liabilities using significant other observable inputs (Level 2) with the assistance of a third-party specialist. We do not have any assets or liabilities measured at fair value on a recurring basis using quoted prices in an active market (Level 1) or significant unobservable inputs (Level 3). Gains and losses related to the fair value changes in the financial assets and liabilities are recorded in general and administrative expense in the consolidated statements of operations. The following table summarizes the fair value balances (in thousands): Fair Value Measurement at December 31, 2024 Total Level 1 Level 2 Level 3 Assets: Company owned life insurance policies (1) $ 25,435 $ — $ 25,435 $ — $ 25,435 $ — $ 25,435 $ — Liabilities: Deferred compensation liabilities $ 19,103 $ — $ 19,103 $ — $ 19,103 $ — $ 19,103 $ — Fair Value Measurement at December 31, 2023 Total Level 1 Level 2 Level 3 Assets: Company owned life insurance policies (1) $ 25,397 $ — $ 25,397 $ — $ 25,397 $ — $ 25,397 $ — Liabilities: Deferred compensation liabilities $ 17,299 $ — $ 17,299 $ — $ 17,299 $ — $ 17,299 $ — (1) Company owned life insurance policies have cash surrender value and are intended to assist in funding deferred compensation liabilities and other benefit plans.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2024
Stock Based Compensation [Abstract]
Stock-Based Compensation	17. STOCK-BASED COMPENSATION See Note 14 – Equity regarding the assignment and assumption of the following plans by Core Laboratories N.V. to Core Laboratories Inc. as a result of the Redomestication Transaction. We have two stock incentive plans: the 2024 Long-Term Incentive Plan (the “LTIP”) and the 2023 Non-Employee Director Stock Incentive Plan (the “Director Plan”). We issue shares from either treasury stock or authorized common stock for the following stock-based compensation plans. In 2024 , we issued 228,413 shares out of treasury stock and 28,311 shares out of authorized common stock. We do not use cash to settle equity instruments issued under stock-based compensation awards. 2024 Long-Term Incentive Plan Under the LTIP, awards may be granted to eligible employees until May 8, 2034, and the maximum number of shares available for award is 14,100,000 shares. At December 31, 2024, approximately 1,569,741 shares remained available for the grant of new awards. We have granted restricted stock awards under two programs: (1) the Performance Share Award Program (“PSAP”); and (2) the Restricted Share Award Program (“RSAP”). Performance Share Award Program The PSAP allows us to compensate our executive and senior management teams as we meet or exceed our business objectives. The PSAP shares are unvested and may not be sold, assigned, pledged, hedged, margined or otherwise transferred by an award recipient until such time as, and then only to the extent that, the restricted performance shares have vested. In the event of a change in control (as defined in the LTIP) prior to the last day of the Performance Period, as defined, all of the award recipient’s restricted performance shares will vest as of the effective date of such change in control. Subject to continued employment with us, or upon death or disability, PSAP shares vest if we meet or exceed our business objectives. Stock compensation expense includes $ 3.5 million, $ 6.5 million and $ 3.9 million of additional non-cash stock compensation expense in the years ended December 31, 2024, 2023 and 2022, respectively, for certain members of our executive management team who became retirement eligible during those years. The additional stock compensation expense has been recorded in accordance with FASB ASC Topic 718, “Compensation - Stock Compensation”, which states that the period over which stock compensation expense is recognized should not extend beyond the eligible retirement age as defined in each executive’s PSAP award agreement. The PSAP awards remain unvested until the end of the performance period, and it can be determined whether the performance criteria have been achieved. The executive will not forfeit the right to vest in the awarded shares if they voluntarily retire from the Company after attaining the retirement age as defined in each agreement. These amounts are reflected in the totals below. On February 17, 2022, certain members of our executive and senior management teams were awarded rights to receive an aggregate of up to 362,254 shares, which include shares that may be awarded if above target level. The target level is achieved if our calculated return on invested capital (“ROIC”), as defined in the PSAP agreement, achieves certain performance criteria as compared to the Bloomberg Peer Group , as defined in the PSAP agreement, at the end of the performance period, which ends on the last trading day of 2024. Shares may be awarded above the target level, subject to ROIC performance and certain total shareholder return (“TSR”) performance criteria, as defined in the PSAP agreement. This arrangement is recorded as an equity award that requires us to recognize compensation expense originally estimated at $ 9.3 million over the shorter of the 3 -year performance period or requisite service period, as determined for each participant individually. In 2024, we reversed $ 4.6 million of previously recognized expense to revalue the awards to their grant date fair value, upon final determination of the performance criteria and certain forfeitures during the year. We have recognized expense of $ 1.2 million and $ 6.4 million in 2023 and 2022, respectively. We issued a total of 112,389 awards valued at $ 3.0 million. The participants surrendered 69,116 shares to settle any personal tax liabilities which may result from the award, as permitted by the agreement. We recorded these surrendered shares as treasury stock with an aggregate cost of $ 1.2 million at $ 17.31 per share. On February 16, 2023, certain members of our executive and senior management teams were awarded rights to receive an aggregate of up to 507,410 shares, which include shares that may be awarded if above target level. The target level is achieved if our calculated ROIC, as defined in the PSAP agreement, achieves certain performance criteria as compared to the Bloomberg Peer Group , as defined in the PSAP agreement, at the end of the performance period, which ends on the last trading day of 2025. Shares may be awarded above the target level, subject to ROIC performance and certain TSR performance criteria, as defined in the PSAP agreement. This arrangement is recorded as an equity award that requires us to recognize compensation expense estimated at $ 12.3 million over the shorter of the 3 -year performance period or requisite service period, as determined for each participant individually. We reduced the estimated expense by $ 1.2 million in 2024 based on current expected performance levels, and we have recognized expense of $ 0.4 million and $ 8.4 million in 2024 and 2023, respectively. The unrecognized compensation expense is expected to be recognized over an estimated amortization period of 12 months. On February 15, 2024, certain members of our executive and senior management teams were awarded rights to receive an aggregate of up to 830,785 shares, which include shares that may be awarded if above target level. The target level is achieved if our calculated ROIC, as defined in the PSAP agreement, achieves certain performance criteria as compared to the Bloomberg Peer Group, as defined in the PSAP agreement, at the end of the performance period, which ends on the last trading day of 2026 and shares awarded above the target level, subject to ROIC performance and certain TSR performance criteria, as defined in the PSAP agreement. This arrangement is recorded as an equity award that requires us to recognize compensation expense estimated at $ 11.8 million over the shorter of the 3 -year performance period or requisite service period, as determined for each participant individually. We have recognized expense of $ 4.4 million in 2024. The unrecognized compensation expense is expected to be recognized over an estimated amortization period of 24 months. Restricted Share Award Program In 2004, the Compensation Committee of our Board of Directors approved the RSAP to attract and retain key employees, and to better align employee interests with those of our shareholders. Under this arrangement we awarded grants totaling 14,220 shares, 180,450 shares and 25,500 shares in 2024, 2023 and 2022 , respectively. Each of these grants has a vesting period of principally either five or six years , and vests ratably or as specified in the award agreements, on an annual basis. There are no performance accelerators for early vesting for these awards. Awards under the RSAP are classified as equity awards and recorded at the grant-date fair value with the compensation expense recognized over the expected life of the award. As of December 31, 2024, there was $ 4.6 million of unrecognized total stock-based compensation expense relating to non-vested RSAP awards. The unrecognized compensation expense is expected to be recognized over an estimated weighted-average amortization period of 46 months. The grant-date fair value of shares granted was $ 0.2 million, $ 3.6 million and $ 0.5 million in 2024, 2023 and 2022 , respectively. We recognized compensation expense of $ 2.7 mill ion, $ 3.9 million and $ 4.5 million in 2024, 2023 and 2022 , respectively. The total grant-date fair value, which is the intrinsic value, of the shares vested was $ 3.4 million, $ 4.1 million and $ 5.3 million in 2024, 2023 and 2022, respectively. 2023 Non-Employee Director Stock Incentive Plan Under the Director Plan, awards may be granted until June 28, 2033 and the maximum number of shares available for award under this plan is 1,400,000 shares. As of December 31, 2024, approximately 436,340 shares remained available for the grant of new awards. We have granted restricted stock awards under the Restricted Share Award Program for Non-Employee Directors (the “Director Program”). The Compensation Committee of our Board of Directors approved the Program to compensate our non-employee Directors. Under this arrangement we awarded grants totaling 55,902 shares, 38,514 shares and 32,910 shares in 2024, 2023 and 2022, respectively. All shares awarded have a vesting period of one year for each grant. There are no performance accelerators for early vesting for these awards. Awards under the Program are classified as equity awards and recorded at the grant-date fair value with compensation expense recognized over the expected life of the award. As of December 31, 2024 , there was $ 0.2 million of unrecognized stock-based compensation relating to non-vested Director Program awards. The unrecognized compensation expense is expected to be recognized over an estimated weighted-average amortization period of 3 months . The grant-date fair value of shares granted was $ 1.0 million, $ 0.9 million and $ 1.0 million in 2024, 2023 and 2022 , respectively, and we have recognized compensation expense of $ 0.8 million, $ 0.9 million and $ 1.0 million in 2024, 2023 and 2022, respectively. Equity Compensation Plan Information Non-vested restricted share awards outstanding as of December 31, 2023 and changes during the year under both the LTIP and the Director Plan are as follows: For the Year Ended December 31, 2024 Number of Shares Weighted Average Grant Date Fair Value per Share Non-vested at December 31, 2023 1,234,487 $ 24.71 Granted 900,907 $ 14.40 Vested ( 256,724 ) $ 28.19 Forfeited ( 308,955 ) $ 24.08 Non-vested at December 31, 2024 1,569,715 $ 18.35 Stock-based compensation expense under both the LTIP and the Director Plan recognized in the consolidated statement of operations is as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 Cost of services and product sales $ 1,847 $ 4,625 $ 4,572 General and administrative expense 1,908 9,346 3,184 Total stock-based compensation expense $ 3,755 $ 13,971 $ 7,756

Impairments and Other Charges

Impairments and Other Charges	12 Months Ended
	Dec. 31, 2024
Asset Impairment Charges [Abstract]
Impairments and Other Charges	18. IMPAIRMENTS AND OTHER CHARGES The geopolitical conflict between Russia and Ukraine, which began in February 2022 and has continued through December 31, 2024, has resulted in disruptions to our operations in Russia and Ukraine. As of December 31, 2024, all laboratory facilities, offices, and locations in Russia and Ukraine continued to operate with no significant impact to local business operations. Therefore, we determined there was no triggering event for long-lived assets in Russia and Ukraine, and no impairment assessments have been performed as of December 31, 2024. For the years ended December 31, 2024, 2023 and 2022 , there were no triggering events during the year, and we determined there was no impairment for any of our long-lived assets or asset groups. We completed our annual impairment assessment of indefinite lived intangible assets and goodwill of our reporting units for the years ended December 31, 2024, 2023 and 2022 , by performing qualitative assessments, which indicated we did not meet the threshold of more likely than not that there was impairment and therefore no quantitative tests were required. No impairments were recorded for our indefinite lived intangible assets or goodwill for the years ended December 31, 2024, 2023 and 2022 .

Other (Income) Expense, Net

Other (Income) Expense, Net	12 Months Ended
	Dec. 31, 2024
Other Income and Expenses [Abstract]
Other (Income) Expense, Net	19. OTHER (INCOME) EXPENSE, NET The components of other (income) expense, net are as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 Gain on sale of assets $ ( 1,779 ) $ ( 200 ) $ ( 1,068 ) Results of non-consolidated subsidiaries ( 236 ) ( 394 ) ( 294 ) Foreign exchange (gain) loss, net 1,197 176 229 Rents and royalties ( 1,922 ) ( 698 ) ( 709 ) Return on pension assets and other pension costs ( 1,178 ) ( 1,365 ) ( 545 ) Loss on lease abandonment and other exit costs 699 1,146 — Assets write-down 1,110 1,143 — Insurance and other settlements ( 8,432 ) ( 604 ) ( 669 ) Severance and other charges 985 — 3,332 ATM termination costs — 455 — Other, net ( 397 ) ( 509 ) ( 998 ) Total other (income) expense, net $ ( 9,953 ) $ ( 850 ) $ ( 722 ) In 2024 and 2022, we sold certain ownership interest in mineral rights of certain properties for a net gain of $ 1.4 million and $ 0.7 million, respectively, which is included in gain on sale of assets. During the years ended December 31, 2024 and 2023, we abandoned certain leases in the U.S. and Canada and incurred lease abandonment and other exit costs of $ 0.7 million and $ 1.1 million, respectively. As a result of consolidating and exiting these facilities, the associated leasehold improvements, right of use assets and other assets of $ 1.1 million and $ 1.1 million were abandoned and expensed during the years ended December 31, 2024 and 2023, respectively. In February 2024, we had a fire incident at one of our U.K. facilities and we have recorded partial settlements and certain net gains from insurance recovery of $ 8.4 million during the year ended December 31, 2024. Amounts associated with partial settlement for costs incurred and loss of income from business interruption are $ 4.0 million, and net gains associated with property, plant and equipment are $ 4.4 million. During the year ended December 31, 2023, the State of Louisiana expropriated the access road to one of our facilities and paid us a settlement of $ 0.6 million. The North America mid-continent winter storm in February 2021 caused business interruptions and property losses to certain facilities, and we received insurance settlements of $ 0.7 million in 2022. During the year ended December 31, 2023, we wrote off previously deferred costs of $ 0.5 million upon termination of our 2022 ATM Program. See Note 14 - Equity for additional information. Foreign Currency Risk We operate in a number of international areas which exposes us to foreign currency exchange rate risk. We do not currently hold or issue forward exchange contracts or other derivative instruments for hedging or speculative purposes. Foreign exchange gains and losses result from fluctuations in the USD against foreign currencies and are included in other (income) expense, net in the consolidated statements of operations. We recognized foreign exchange losses in countries where the USD weakened against the local currency and we had net monetary liabilities denominated in the local currency; as well as countries where the USD strengthened against the local currency and we had net monetary assets denominated in the local currency. We recognized foreign exchange gains in countries where the USD strengthened against the local currency and we had net monetary liabilities denominated in the local currency and in countries where the USD weakened against the local currency and we had net monetary assets denominated in the local currency. Foreign exchange (gain) loss, net is summarized in the following table (in thousands): For the Years Ended December 31, 2024 2023 2022 Angolan Kwanza $ ( 46 ) $ 188 $ ( 2 ) Australian Dollar ( 2 ) 81 9 British Pound 117 ( 408 ) 212 Canadian Dollar 293 156 238 Colombian Peso 62 92 ( 430 ) Euro 41 438 ( 382 ) Indonesian Rupiah 315 82 379 Nigerian Naira 126 ( 74 ) ( 39 ) Norwegian Krone ( 20 ) 103 ( 31 ) Russian Ruble 36 ( 375 ) 35 Turkish Lira 53 ( 472 ) 114 Other currencies, net 222 365 126 Foreign exchange (gain) loss, net $ 1,197 $ 176 $ 229

Earnings per Share

Earnings per Share	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Earnings per Share	20. EARNINGS PER SHARE We compute basic earnings per share by dividing net income attributable to Core Laboratories Inc. by the number of weighted average common shares outstanding during the period. Diluted earnings per share includes the incremental effect of contingently issuable shares from performance and restricted stock awards, as determined using the treasury stock method. The Redomestication Transaction had no effect on earnings per share for the periods presented. The following table summarizes the calculation of weighted average common shares outstanding used in the computation of basic and diluted earnings per share (in thousands): For the Years Ended December 31, 2024 2023 2022 Weighted average common shares outstanding - basic 46,897 46,683 46,334 Effect of dilutive securities: Restricted shares 52 97 71 Performance shares 736 743 408 Weighted average common shares outstanding - diluted 47,685 47,523 46,813

Segment Reporting and Other Dis

Segment Reporting and Other Disaggregated Information	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Segment Reporting and Other Disaggregated Information	21. SEGMENT REPORTING AND OTHER DISAGGREGATED INFORMATION Segment Reporting We operate our business in two segments. These complementary operating segments provide different services and products and utilize different technologies for evaluating and improving reservoir performance and increasing oil and gas recovery from new and existing fields: • Reservoir Description : Encompasses the characterization of petroleum reservoir rock and reservoir fluids samples to increase production and improve recovery of crude oil and natural gas from our clients’ reservoirs. We provide laboratory-based analytical and field services to characterize properties of crude oil and crude oil-derived products to the oil and gas industry. Services associated with these fluids include determining the quality and measuring the quantity of the reservoir fluids and their derived products, such as gasoline, diesel and biofuels. We also provide proprietary and joint industry studies based on these types of analyses and manufacture associated laboratory equipment. In addition, we provide reservoir description capabilities that support various activities associated with energy transition projects, including services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities around lithium and other elements necessary for energy storage. • Production Enhancement : Includes services and manufactured products associated with reservoir well completions, perforations, stimulation, production and well abandonment. We provide integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects. We use the same accounting policies to prepare our operating segment results as are used to prepare our consolidated financial statements. All interest and other non-operating income (expense) is attributable to Corporate & Other and is not allocated to specific operating segments. Our chief operating decision maker (“CODM”) is our chief executive officer and Chairman of the Board of Directors. The CODM uses revenue from unaffiliated clients and segment operating income to allocate resources, primarily for working capital, staffing, and capital expenditures, during the annual budgeting process and monthly when comparing actual results to budgeted and forecasted results. Summarized financial information of our operating segments is shown in the following table (in thousands): As at and for the years ended: Reservoir Description Production Enhancement Corporate & Other (1) Consolidated December 31, 2024 CODM Measure - Revenue from unaffiliated clients $ 346,146 $ 177,702 $ — $ 523,848 Reconciliation of CODM measure - revenue from unaffiliated clients to segment operating income: Inter-segment revenue 123 214 ( 337 ) — Cost of services and product sales 269,169 151,916 ( 563 ) 420,522 Depreciation and amortization 10,660 4,293 — 14,953 General and administrative expense (2) 25,531 14,239 — 39,770 Other operating (income) expense, net (3) ( 11,542 ) 550 ( 158 ) ( 11,150 ) Foreign exchange (gain) loss, net (3) 985 306 ( 94 ) 1,197 CODM Measure - Segment operating income 51,466 6,612 478 58,556 Supplemental Disclosures: Total assets 322,764 149,446 118,196 590,406 Capital expenditures 11,413 1,318 297 13,028 December 31, 2023 CODM Measure - Revenue from unaffiliated clients $ 333,345 $ 176,445 $ — $ 509,790 Reconciliation of CODM measure - revenue from unaffiliated clients to segment operating income: Inter-segment revenue 156 249 ( 405 ) — Cost of services and product sales 256,480 145,194 ( 1,717 ) 399,957 Depreciation and amortization 11,462 4,322 — 15,784 General and administrative expense (2) 25,792 14,467 — 40,259 Other operating (income) expense, net (3) ( 994 ) ( 5 ) ( 27 ) ( 1,026 ) Foreign exchange (gain) loss, net (3) ( 278 ) 197 257 176 CODM Measure - Segment operating income 41,039 12,519 1,082 54,640 Supplemental Disclosures: Total assets 309,162 161,359 115,874 586,395 Capital expenditures 8,312 1,808 459 10,579 December 31, 2022 CODM Measure - Revenue from unaffiliated clients $ 307,691 $ 182,044 $ — $ 489,735 Reconciliation of CODM measure - revenue from unaffiliated clients to segment operating income: Inter-segment revenue 523 315 ( 838 ) — Cost of services and product sales 250,182 145,117 ( 1,644 ) 393,655 Depreciation and amortization 12,207 4,954 — 17,161 General and administrative expense (2) 24,264 13,853 — 38,117 Other operating (income) expense, net (3) ( 1,089 ) 1,414 ( 1,276 ) ( 951 ) Foreign exchange (gain) loss, net (3) ( 252 ) 670 ( 189 ) 229 CODM Measure - Segment operating income 22,902 16,351 2,271 41,524 Supplemental Disclosures: Total assets 307,108 159,628 111,618 578,354 Capital expenditures 7,458 2,181 577 10,216 (1) “Corporate and other” represents those items not directly related to a particular operating segment and eliminations. (2) General and administrative expense is presented as a total amount to the CODM and consists primarily of employee benefits, professional fees and information technology costs. (3) Other remaining balance is included in other (income) expense, net. See Note 19 - Other (income) expense, net for further detail. Disaggregated Revenue We derive our revenue from services and product sales contracts with clients primarily in the oil and gas industry. No single client accounted for 10% or more of revenue in any of the periods presented. Summarized financial information of our contracts is shown in the following table (in thousands): For the Years Ended December 31, 2024 2023 2022 Reservoir Description Services $ 334,325 $ 322,921 $ 296,201 Production Enhancement Services 53,880 48,993 50,773 Total Revenue - Services $ 388,205 $ 371,914 $ 346,974 Reservoir Description Product sales $ 11,821 $ 10,424 $ 11,490 Production Enhancement Product sales 123,822 127,452 131,271 Total Revenue - Product sales $ 135,643 $ 137,876 $ 142,761 Total Revenue $ 523,848 $ 509,790 $ 489,735 We attribute service revenue to the country in which the service was performed rather than where the reservoir or project is located while we attribute product sales revenue to the country where the product was shipped as we feel this gives a clearer view of our operations. We do, however, have significant levels of service revenue performed and recorded in the U.S. that are sourced from projects on non-U.S. oilfields. Summarized financial information of our geographic regions is shown in the following table (in thousands): Other As at and for the years ended: United States Countries (1) (2) Consolidated December 31, 2024 Revenue $ 178,895 $ 344,953 $ 523,848 Property, plant and equipment, net 46,666 50,397 97,063 December 31, 2023 Revenue $ 178,549 $ 331,241 $ 509,790 Property, plant and equipment, net 50,792 48,834 99,626 December 31, 2022 Revenue $ 166,701 $ 323,034 $ 489,735 Property, plant and equipment, net 54,384 50,644 105,028 (1) Revenue earned in other countries, was not individually greater than 10 % of our consolidated revenue in 2024, 2023 and 2022 . (2) Property, plant and equipment, net in other countries, was not individually greater than 10 % of our consolidated property, plant and equipment, net in 2024, 2023 and 2022 .

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Account	12 Months Ended
	Dec. 31, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II - Valuation and Qualifying Account	CORE LABORATORIES INC. Schedule II - Valuation and Qualifying Account (In thousands) Balance at Beginning of Period Additions Charged to/(Recovered from) Expense Write-offs Other (1) Balance at End of Period Year ended December 31, 2024 Reserve for credit losses $ 2,280 $ 1,203 $ ( 298 ) $ 7 $ 3,192 Year ended December 31, 2023 Reserve for credit losses $ 2,214 $ 179 $ ( 113 ) $ — $ 2,280 Year ended December 31, 2022 Reserve for credit losses $ 3,225 $ ( 6 ) $ ( 1,006 ) $ 1 $ 2,214 (1) Comprised primarily of differences due to changes in exchange rate.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The Redomestication Transaction has been accounted for as a transaction between entities under common control. Accordingly, Core Laboratories Inc. recorded the assets and liabilities transferred at their carrying values at the date of transfer. All common shares in Core Laboratories N.V., at par value EUR 0.02 , were canceled and exchanged for common stock in Core Laboratories Inc., at par value $ 0.01 , on a one-for-one basis. Core Laboratories Inc.’s common stock par value was decreased by $ 0.7 million for the difference between the total par value of common stock of Core Laboratories Inc. and the total par value of common shares of Core Laboratories N.V. at the date of transfer, with an offset to additional paid in capital. There is no difference between the combined separate entities prior to the Redomestication Transaction and the combined separate entities after the Redomestication Transaction, therefore, these financial statements, reported as though the exchange of equity interests had occurred at the beginning of the reporting period, and comparative information do not differ from amounts previously reported under Core Laboratories N.V.’s consolidated financial statements. These financial statements should be read in conjunction with Core Laboratories N.V.’s Quarterly Report on Form 10-Q for the three months ended March 31, 2023 and Core Laboratories N.V.’s Annual Report on Form 10-K for the year ended December 31, 2022, including Note 2 - Summary of Significant Accounting Policies. There have been no changes to the accounting policies of the combined entities during the years ended December 31, 2024 and 202 3. The accompanying consolidated financial statements include the accounts of Core Laboratories Inc. and its subsidiaries for which we have a controlling voting interest and/or a controlling financial interest. These financial statements have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”). We use the equity method of accounting for investments in which we have less than a majority interest and do not exercise control but do exert significant influence. Non-controlling interest has been recorded to reflect outside ownership attributable to consolidated subsidiaries that are less than 100% owned. All inter-company transactions and balances have been eliminated in consolidation. Certain reclassifications were made to prior period amounts in order to conform to the current period presentation. These reclassifications had no impact on the reported net income or cash flows for the years ended December 31, 2023 and 2022.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Pronouncements Adopted in 2024 In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an annual and interim basis. The amendment is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We adopted the guidance for the year ended December 31, 2024 and applied it retrospectively to all prior periods presented in the financial statements. Upon adoption, our disclosures regarding segment reporting was expanded. See Note 21 - Segment Reporting and Other Disaggregated Information. Pronouncements Not Yet Effective In December 2023, FASB issued ASU 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures to improve transparency of income tax disclosures, primarily by requiring consistent categories and greater disaggregation of information in the rate reconciliation and income taxes paid disaggregated by jurisdiction. The amendment is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendment should be applied prospectively; however, retrospective application is permitted. Upon adoption, our disclosures regarding income taxes will be expanded accordingly. In November 2024, FASB issued ASU 2024-03 Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40) to improve disclosures about a public business entity’s expenses, by providing more detailed information about the types of expenses in commonly presented expense captions. As amended by ASU 2025-01 issued in January 2025, the amendment is effective for annual periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendment may be applied prospectively or retrospectively. Upon adoption, our disclosures regarding expenses will be expanded.
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We evaluate our estimates on an ongoing basis and utilize our historical experience, as well as various other assumptions that we believe are reasonable in a given circumstance, in order to make these estimates. Actual results could differ from our estimates, as assumptions and conditions change. The following accounts, among others, require us to use estimates and assumptions: ▪ allowance for credit losses; ▪ obsolete inventory; ▪ depreciation and amortization; ▪ long-lived assets, intangibles and goodwill; ▪ income taxes; ▪ pensions and other postretirement benefits; ▪ stock-based compensation; and ▪ leases. Accounting policies relating to these accounts and the nature of these estimates are further discussed under the applicable caption. For each of these critical estimates it is at least reasonably possible that changes in these estimates will occur in the short term which may impact our financial position or results of operations.
Foreign Currencies	Foreign Currencies Our functional currency is the U.S. Dollar (“USD”). All inter-company financing, transactions and cash flows with our subsidiaries are transacted in USD. Revenue and expenses denominated in other currencies are measured at the applicable month-end exchange rate which approximates the average exchange rate. We remeasure monetary assets and liabilities denominated in other currencies to USD at year-end exchange rates. Non-monetary items, depreciation, amortization and certain components of cost of sales are measured at historical rates. Remeasurement and settlement difference are included in other (income) expense, net in the accompanying consolidated statements of operations. See Note 19 - Other (Income) Expense, net .
Concentration of Credit Risk	Concentration of Credit Risk Our financial instruments that potentially subject us to concentrations of credit risk relate primarily to cash and cash equivalents and trade accounts receivable. All cash and cash equivalents are on deposit at commercial banks or investment firms with significant financial resources. Our trade receivables are with a variety of domestic, international and national oil and gas companies. We had no clients who provided more than 10% of our revenue for the years ended December 31, 2024, 2023 and 2022 . We consider our credit risk related to trade accounts receivable to be limited due to the creditworthiness and financial resources of our clients. We apply the expected credit losses methodology for measurement of credit losses on financial assets measured at amortized cost basis. We evaluate our estimate for credit losses on an on-going basis throughout the year.
Concentration of Interest Rate Risk	Concentration of Interest Rate Risk We are exposed to interest rate risk on our revolving credit facility debt, which carries a variable interest rate. We are exposed to interest rate risk on our Senior Notes which carry a fixed interest rate, but whose fair value will fluctuate based on changes in interest rates and market perception of our credit risk. See Note 11 - Long-term Debt, net .
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents include all short-term, highly liquid instruments purchased with an original maturity of three months or less. These items are carried at cost, which approximates fair value.
Accounts Receivable	Accounts Receivable Trade accounts receivable are recorded at their invoiced amounts and do not bear interest. We perform ongoing credit evaluations of our clients, monitor collections and payments, consider our historical collection experience and our current aging of client receivables outstanding, in addition to client’s representations and our understanding of the economic environment in which our clients operate. Based on our review we establish or adjust allowances for credit losses for specific clients and the accounts receivable, as a whole, and recognize expense. When an account is determined to be uncollectible, we charge the receivable to our allowance for credit losses. The net carrying value of accounts receivable approximates fair value.
Contract Assets and Liabilities	Contract Assets and Liabilities Contract assets and liabilities arise from differences in timing of revenue recognition, billings and cash collections. Contract assets include our right to payment for goods and services already transferred to a customer when the right to payment is conditional on something other than the passage of time. For example, we have contracts where we recognize revenue over time but do not have a contractual right to payment until we complete the performance obligations. Contract liabilities consist of advance payments received and billings in excess of revenue recognized. We generally receive up-front payments relating to our consortia studies. We recognize revenue over the life of the study as the testing and analysis results are made available to our consortia members. We classify contract liabilities for contracts with a duration greater than twelve months as current or non-current based on the timing of revenue recognition. The current portion of contract liabilities is included in unearned revenues and the non-current portion of contract liabilities is included in other long-term liabilities.
Inventories	Inventories Inventories consist of manufactured goods, materials and supplies used for sales or services to clients. Inventories are stated at the lower of cost or estimated net realizable value. Inventory costs are recorded at standard cost which approximates the first-in, first-out method.
Prepaid Expenses and Other Current Assets	Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets are comprised primarily of prepaid insurance, value added taxes and prepaid software licenses.
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment are carried at cost less accumulated depreciation. Major renewals and improvements are capitalized while maintenance and repair costs are charged to expense as incurred. They are depreciated using the straight-line method based on their individual estimated useful lives, except for leasehold improvements, which are depreciated over the remaining lease term, if shorter. We estimate the useful lives and salvage values of our assets based on historical data as follows: Buildings and leasehold improvements 3 - 40 years Machinery and equipment 3 - 10 years When long-lived assets are sold or retired, the remaining costs and related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized in income. We review our long-lived assets for impairment when events or changes in circumstances indicate that their net book value may not be recovered over their remaining service lives. Indicators of possible impairment may include significant declines in activity levels in regions where specific assets or groups of assets are located, extended periods of idle use, declining revenue or cash flow or overall changes in general market conditions. Whenever possible impairment is indicated, we compare the carrying value of the assets or asset groups to the sum of the estimated undiscounted future cash flows expected from use, plus salvage value, less the costs of the subsequent disposition of the assets. If impairment is still indicated, we compare the fair value of the assets to the carrying value and recognize an impairment loss for the amount by which the carrying value exceeds the fair value. We did no t record any material impairment charges relating to our long-lived assets held for use during the years ended December 31, 2024, 2023 and 2022. The geopolitical conflict between Russia and Ukraine, which began in February 2022 and has continued through December 31, 2024, has resulted in disruptions to our operations in Russia and Ukraine. The Company evaluated long-lived assets in Russia and Ukraine as part of our assessment of our assets group and did not identify triggering events as of December 31, 2024. Based on our assessments, we determined there was no impairment for long-lived assets in Russia and Ukraine as of December 31, 2024. See Note 18 - Impairments and Other Charges .
Leases	Leases We have operating leases primarily consisting of offices and lab space, machinery and equipment and vehicles. We determine if an arrangement is an operating or finance lease at inception. Lease assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. Where our lease does not provide an implicit rate, we estimate the discount rate used to discount the future minimum lease payments using our incremental borrowing rate and other information available at the commencement date. Operating leased assets also include all initial direct costs incurred. The lease term may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Operating leased assets are included in right of use (“ROU”) assets and, along with current and long-term operating lease liabilities, are separately presented in our consolidated balance sheet. Financing leased assets are included in property, plant and equipment, net and the related liabilities are included in other current and other long- term liabilities in our consolidated balance sheet. ROU assets are subsequently depreciated over the estimated useful life of the asset and lease liabilities are carried at amortized cost using the effective interest rate method. The Company has elected to apply the short-term lease exemption to all classes of underlying ROU assets. Accordingly, no ROU asset or lease liability is recognized for leases with a term of twelve months or less. The Company has elected to apply the practical expedient for combining lease and non-lease components for vehicle leases and elected not to apply the practical expedient for combining lease and non-lease components to all other classes of underlying ROU assets.
Intangibles and Goodwill	Intangibles and Goodwill Intangible assets, which include trade secrets, patents, technology, agreements not to compete, trade names, and trademarks, are carried at cost less accumulated amortization, for intangibles with a definite life, and any accumulated impairment. Intangibles with definite lives are amortized using the straight-line method based on the estimated useful life of the intangible. We review our intangible assets with definite lives for impairment when events or changes in circumstances indicate that net book value may not be recovered over their remaining service lives. We record goodwill as the excess of the purchase price over the fair value of the net assets acquired in acquisitions accounted for under the purchase method of accounting. Goodwill is not subject to amortization and is tested for impairment annually or more frequently if events or changes in circumstances indicate goodwill is more likely than not impaired. We assess intangibles with indefinite lives and goodwill for impairment by performing a qualitative assessment or a quantitative test. The qualitative assessment is to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value is less than carrying value. If it is concluded that it is more-likely-than not that an impairment exists, a quantitative test is required which compares the estimated fair value to carrying value. If the estimated fair value is less than carrying value, then there is an impairment loss limited to the carrying value. Significant judgments and assumptions are inherent in our estimate of future cash flows used to determine the estimate of the reporting unit’s fair value which include assumptions regarding future revenue growth rates, discount rates and expected margins. See Note 18 - Impairments and Other Charges .
Accounts Payable	Accounts Payable Trade accounts payable are recorded at their invoiced amounts and do not bear interest. The carrying value of accounts payable approximates fair value.
Income Taxes	Income Taxes We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the financial statement and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the asset is expected to be recovered or the liability is expected to be settled. We include interest and penalties from tax judgments in income tax expense. We record a liability for unrecognized tax benefits resulting from uncertain tax positions taken or expected to be taken in our tax return. We also recognize interest and penalties, if any, related to unrecognized tax benefits in income tax expense. See Note 9 - Income Taxes. The Company is subject to controlled foreign corporations Subpart F income (“Subpart F”) tax, which is a tax primarily on passive income from controlled foreign corporations. In addition, the 2017 Tax Cuts and Jobs Act imposed a global intangible low-taxed income (“GILTI”) tax that determines the amount of Subpart F income that must be recognized. The FASB Staff Q&A, Topic 740, No. 5, Accounting for Global Intangible Low-Taxed Income, states that an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in the future years or provide for tax expense related to GILTI in the year the tax is incurred. The Company has elected to recognize tax expense related to GILTI in the year the tax is incurred.
Pension and Other Postretirement Benefit Plans	Pension and Other Postretirement Benefit Plans We provide a non-contributory defined benefit pension plan covering substantially all of our Dutch employees (“Dutch Plan”) who were hired prior to 2000. We recognize net periodic pension costs associated with the Dutch Plan in income and recognize the unfunded status of the plan, if any, as another long-term liability. We recognize the actuarial gains or losses and prior service costs or credits that arise during the period as a component of other comprehensive income. The projection of benefit obligation and fair value of plan assets requires the use of assumptions and estimates. Actual results could differ from those estimates. See Note 12 - Pension and Other Postretirement Benefit Plans . We maintain defined contribution plans for the benefit of eligible employees primarily in Canada, the Netherlands, the United Kingdom and the United States. We expense contributions in the period the contribution is made.
Derivative Instruments	Derivative Instruments We may enter into a variety of derivative instruments in connection with the management of our exposure to fluctuations in interest rates or currency exchange rates. See Note 15 - Derivative Instruments and Hedging Activities . We do not enter into derivatives for speculative purposes.
Comprehensive Income	Comprehensive Income Comprehensive income is comprised of net income and other charges or credits to equity that are not the result of transactions with owners. Accumulated other comprehensive income (loss) consists of prior service costs and unrecognized net actuarial gain or loss from the Dutch pension plan and changes in the fair value of our interest rate swaps. See Note 12 - Pension and Other Postretirement Benefit Plans and Note 15 - Derivative Instruments and Hedging Activities .
Revenue Recognition	Revenue Recognition All of our revenue is derived from contracts with clients. Our contracts include standard commercial payment terms generally acceptable in each region, and do not include financing with extended payment terms. We have no significant obligations for refunds, warranties, or similar obligations. Our revenue does not include taxes collected from our clients. In certain circumstances we apply the guidance in Accounting Standards Codification Topic 606 - Revenue from Contracts with Customers (“Topic 606”) to a portfolio of contracts with similar characteristics. We use estimates and assumptions when accounting for a portfolio that reflect the size and composition of the portfolio of contracts. We recognize revenue at an amount that reflects the consideration expected to be received in exchange for such services or goods as described below by applying the five-step method to: (1) identify the contract(s) with clients; (2) identify the performance obligation(s) in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligation(s) in the contract; and (5) recognize revenue when (or as) we satisfy the performance obligation(s). A performance obligation is a promise in a contract to transfer a distinct service or good to a client and is the unit of account under Topic 606. We have contracts with two general groups of performance obligations: those that require us to perform analysis and/or diagnostic tests in our laboratory or at the client’s wellsite and those from the sale of tools, diagnostic and equipment products and related services. Service Revenue : We provide a variety of services to clients in the oil and gas industry. Where services are provided related to the testing and analysis of rock and fluids, we recognize revenue upon the provision of the test results or analysis to the client. For our design, field engineering and completion diagnostic services, we recognize revenue upon the delivery of those services at the well site or delivery of diagnostic data. In the case of our consortia studies, we have multiple performance obligations and revenue is recognized at the point in time when the testing and analysis results on each contributed core are made available to our consortia members. For arrangements that include multiple performance obligations, we allocate revenue to each performance obligation based on estimates of the price that we would charge the client for each promised service or product if it were sold on a standalone basis. To a lesser extent, we enter into other types of contracts including service arrangements and non-subscription software and licensing agreements. We recognize revenue for these arrangements over time or at a point in time depending on our evaluation of when the client obtains control of the promised services or products. Product Sales Revenue : We manufacture equipment that we sell to our clients in the oil and gas industry. We recognize revenue when control of the promised product is transferred to the client. Control of the product usually passes to the client at the time shipment is made or picked up by the client at our facilities, as defined within the contract. Disaggregation of Revenue We contract with clients for service revenue and/or product sales revenue. We present revenue disaggregated by services and product sales in our consolidated statements of operations. For revenue disaggregated by operating segment, see Note 21 - Segment Reporting and Other Disaggregated Information .
Stock-Based Compensation	Stock-Based Compensation For new awards issued and awards modified, repurchased or canceled, we record compensation expense in the consolidated statements of operations equal to the fair value of the award at the date of the grant, modification, repurchase or cancellation over the requisite service period of the award. The fair value is generally determined by the quoted market price of the Company’s common stock on the date of grant less the discounted value of the expected dividends to be paid over the vesting period. Market vesting conditions, as applicable, are included in the estimation of the fair value of the award. Forfeitures are recognized as they occur.
Non-controlling Interests	Non-controlling Interests We maintain non-controlling interests in several investment ventures. Non-controlling interest have been recorded to reflect outside ownership attributable to consolidated subsidiaries that are less than 100% owned and presented as a separate component of equity in the consolidated balance sheets and income in the consolidated statements of operations and other comprehensive income, respectively. In addition, when a subsidiary is deconsolidated, any retained non-controlling equity investment in the former subsidiary will be initially measured at fair value and recorded as a gain or loss.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Schedule of Property, Plant and Equipment, Useful life	We estimate the useful lives and salvage values of our assets based on historical data as follows: Buildings and leasehold improvements 3 - 40 years Machinery and equipment 3 - 10 years

Contract Assets and Liabiliti_2

Contract Assets and Liabilities (Tables)	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Contract Assets and Liabilities	The balance of contract assets and contract liabilities consist of the following (in thousands): December 31, 2024 2023 Contract assets: Current $ 370 $ 1,293 $ 370 $ 1,293 Contract liabilities: Current $ 560 $ 299 $ 560 $ 299 December 31, 2024 Estimate of when contract liabilities will be recognized as revenue: Within 12 months $ 560

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories consist of the following (in thousands): December 31, 2024 2023 Finished goods $ 27,127 $ 30,508 Parts and materials 28,953 37,670 Work in progress 3,322 3,524 Total inventories $ 59,402 $ 71,702

Property, Plant, and Equipment

Property, Plant, and Equipment (Tables)	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment, Net	The components of property, plant and equipment, net are as follows (in thousands): December 31, 2024 2023 Land $ 10,402 $ 10,652 Building and leasehold improvements 117,682 120,545 Machinery and equipment 283,296 284,225 Total property, plant and equipment 411,380 415,422 Less: Accumulated depreciation ( 314,317 ) ( 315,796 ) Property, plant and equipment, net $ 97,063 $ 99,626

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Schedule of Components of Lease Expense and Other Information	The components of lease expense and other information are as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 Consolidated Statements of Operations: Operating lease expense $ 16,998 $ 17,454 $ 16,595 Short-term lease expense 1,720 1,768 1,784 Variable lease expense 1,719 1,758 1,414 Sublease income ( 227 ) ( 113 ) — Total lease expense $ 20,210 $ 20,867 $ 19,793 Consolidated Statements of Cash Flows: Operating cash flows - operating leases payments $ 16,708 $ 16,541 $ 16,598 Right of use assets obtained in exchange for operating lease liabilities $ 14,237 $ 17,005 $ 5,520 Other information: Weighted-average remaining lease term - operating leases 8.70 years 9.24 years 6.88 years Weighted-average discount rate - operating leases 5.45 % 5.32 % 4.62 %
Schedule of Undiscounted Cash Flows for Non-cancellable Leases	Scheduled undiscounted lease payments for non-cancellable operating leases consist of the following (in thousands): December 31, 2024 Operating Leases Operating Sublease 2025 $ 13,245 $ ( 231 ) 2026 10,417 ( 236 ) 2027 8,324 ( 241 ) 2028 6,586 ( 163 ) 2029 4,388 — Thereafter 25,505 — Total undiscounted lease payments 68,465 $ ( 871 ) Less: Imputed interest ( 14,432 ) Total operating lease liabilities $ 54,033

Intangibles and Goodwill (Table

Intangibles and Goodwill (Tables)	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Components of Intangible Assets	The components of intangibles, net are as follows (in thousands): December 31, 2024 2023 Gross Accumulated Amortization Gross Accumulated Amortization Useful life in years Carrying Value and Impairment Carrying Value and Impairment Acquired trade secrets 2 - 20 $ 4,278 $ 3,967 $ 4,278 $ 3,756 Acquired patents and technology 4 - 15 15,722 14,243 15,744 13,953 Agreements not to compete 2 - 5 1,105 1,105 1,105 1,105 Acquired trade names and trademarks Indefinite 4,624 11 4,624 11 Total intangibles, net $ 25,729 $ 19,326 $ 25,751 $ 18,825
Summary of Estimated Amortization Expense Related to Intangibles	Our estimated amortization expense relating to these intangibles for the next five years is summarized in the following table (in thousands): December 31, 2024 2025 $ 359 2026 $ 231 2027 $ 193 2028 $ 98 2029 $ 35

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Income before Income Taxes, Domestic and Foreign	The components of income before income taxes are as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 United States $ ( 11,045 ) $ 3,907 $ ( 4,099 ) Other countries 57,232 37,303 34,053 Income before income taxes $ 46,187 $ 41,210 $ 29,954
Schedule of Components of Income Tax Expense	The components of income tax expense are as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 Current: United States $ 1,231 $ 1,204 $ 1,269 Other countries 12,205 13,446 9,784 State and provincial ( 22 ) 597 ( 100 ) Total current 13,414 15,247 10,953 Deferred: United States ( 2,487 ) 1,555 ( 908 ) Other countries 2,842 ( 12,343 ) ( 162 ) State and provincial 265 ( 274 ) 413 Total deferred 620 ( 11,062 ) ( 657 ) Income tax expense $ 14,034 $ 4,185 $ 10,296
Schedule of Effective Income Tax Rate Reconciliation	The differences in income tax expense computed using the statutory income tax rate and our income tax expense as reported in the accompanying consolidated statements of operations are as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 Tax at the statutory income tax rate (1) $ 9,553 $ 8,139 $ 7,368 International earnings taxed at rates other than the statutory income tax rate (1) 2,237 5,749 5,923 Non-deductible expenses 1,092 2,168 3,096 Net operating loss ( 190 ) 4,661 ( 3,627 ) Foreign earnings currently taxed in the U.S. 3,934 3,077 — Change in valuation allowance 337 ( 1,107 ) 1,943 State and provincial taxes 136 243 662 Tax credits ( 5,823 ) ( 7,410 ) ( 6,872 ) Unremitted earnings of subsidiaries 891 ( 14,464 ) ( 27 ) Adjustments of prior year taxes ( 935 ) 701 ( 3,488 ) Adjustments of income tax reserves 208 519 ( 184 ) Foreign exchange ( 964 ) ( 171 ) ( 576 ) UK tax rate change — — 676 Accrued withholding taxes 3,262 1,639 1,883 Other 296 441 3,519 Income tax expense $ 14,034 $ 4,185 $ 10,296 (1) Based on the U.S. statutory corporate income tax rate of 21 % for 2024 and 2023 and the Netherlands statutory income tax rate of 25 % for 2022.
Schedule of Deferred Tax Assets and Liabilities	Deferred tax assets and liabilities result from various temporary differences between the financial statement carrying value and their tax basis. Deferred tax assets and liabilities are summarized as follows (in thousands): December 31, 2024 2023 Deferred tax assets: Net operating loss carry-forwards $ 6,279 $ 7,814 Tax credit carry-forwards 5,811 2,144 Accruals for compensation 9,236 8,985 Accruals for inventory capitalization 1,673 1,621 Unrealized benefit from corporate restructuring 36,762 40,963 Intangibles 1,886 1,584 Unrealized benefit plan loss 962 1,224 Unrealized foreign exchange 2,819 2,875 Unearned revenue 2,632 3,453 Interest carry-forward 11,367 7,912 Other 1,074 1,401 Total deferred tax assets 80,501 79,976 Valuation allowance ( 8,812 ) ( 8,276 ) Net deferred tax assets 71,689 71,700 Deferred tax liabilities: Property, plant and equipment, net ( 2,840 ) ( 3,566 ) Accrued withholding taxes ( 11,279 ) ( 10,466 ) Unrealized foreign exchange ( 1,542 ) ( 988 ) Other ( 198 ) ( 176 ) Total deferred tax liabilities ( 15,859 ) ( 15,196 ) Net deferred income taxes $ 55,830 $ 56,504 The table below summarizes the net deferred tax assets and net deferred tax liabilities by legal jurisdiction (in thousands): December 31, 2024 2023 Long-term deferred tax assets, net $ 69,613 $ 69,201 Long-term deferred tax liabilities, net ( 13,783 ) ( 12,697 ) Net deferred income taxes $ 55,830 $ 56,504
Summary of Income Tax Contingencies	A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 Unrecognized tax benefits at January 1, $ 3,483 $ 3,509 $ 4,327 Tax positions, current period 138 144 230 Tax positions, prior period ( 165 ) 68 ( 867 ) Settlements with taxing authorities — — ( 19 ) Lapse of applicable statute of limitations ( 184 ) ( 238 ) ( 162 ) Unrecognized tax benefits at December 31, $ 3,272 $ 3,483 $ 3,509

Other Assets (Tables)

Other Assets (Tables)	12 Months Ended
	Dec. 31, 2024
Table Text Block Supplement [Abstract]
Schedule of Other Assets	Other assets consist of the following (in thousands): December 31, 2024 2023 Cash surrender value of life insurance policies $ 25,435 $ 25,397 Investments in unconsolidated affiliates 5,080 4,844 Other 4,273 3,978 Total other assets $ 34,788 $ 34,219

Long-Term Debt, Net (Tables)

Long-Term Debt, Net (Tables)	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	Debt is summarized in the following table (in thousands): December 31, Interest Rate Maturity Date 2024 2023 2021 Senior Notes Series A (1) 4.09 % January 12, 2026 $ 45,000 $ 45,000 2021 Senior Notes Series B (1) 4.38 % January 12, 2028 15,000 15,000 2023 Senior Notes Series A (2) 7.25 % June 28, 2028 25,000 25,000 2023 Senior Notes Series B (2) 7.50 % June 28, 2030 25,000 25,000 Credit Facility 18,000 56,000 Total long-term debt 128,000 166,000 Less: Debt issuance costs ( 1,889 ) ( 2,866 ) Long-term debt, net $ 126,111 $ 163,134 (1) Interest is payable semi-annually on June 30 and December 30. (2) Interest is payable semi-annually on March 28 and September 28.

Pension and Other Postretirem_2

Pension and Other Postretirement Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets	The following table summarizes the change in the projected benefit obligation and the fair value of plan assets for the Dutch Plan (in thousands): For the Years Ended December 31, 2024 2023 Projected Benefit Obligation: Projected benefit obligation at beginning of year $ 43,985 $ 40,059 Interest cost 1,403 1,480 Benefits paid and administrative expenses ( 1,587 ) ( 1,505 ) Actuarial (gain) loss, net ( 1,114 ) 2,905 Unrealized (gain) loss on foreign exchange ( 2,018 ) 1,046 Projected benefit obligation at end of year $ 40,669 $ 43,985 Fair Value of Plan Assets: Fair value of plan assets at beginning of year $ 41,713 $ 37,376 Increase (decrease) in plan asset value 12 3,137 Employer contributions 742 1,719 Benefits paid and administrative expenses ( 1,587 ) ( 1,505 ) Unrealized gain (loss) on foreign exchange ( 1,931 ) 986 Fair value of plan assets at end of year $ 38,949 $ 41,713 Under-funded status of the plan at end of the year $ ( 1,720 ) $ ( 2,272 ) Accumulated Benefit Obligation $ 40,669 $ 41,727
Schedule of Assumptions Used	The following actuarial assumptions were used to determine the actuarial present value of our projected benefit obligation and the net periodic pension cost for the Dutch Plan: For the Years Ended December 31, 2024 2023 Weighted average assumed discount rate 3.48 % 3.27 % Expected long-term rate of return on plan assets 3.48 % 3.27 % Weighted average rate of compensation increase 2.00 % 2.10 %
Schedule of Amounts Recognized in Balance Sheet	Amounts recognized for the Dutch Plan in the consolidated balance sheets consist of (in thousands): December 31, 2024 2023 Deferred tax asset $ 440 $ 582 Other long-term liabilities 1,720 2,272 Accumulated other comprehensive loss ( 5,890 ) ( 5,914 )
Schedule of Components of Net Periodic Pension Cost	The components of net periodic pension cost for the Dutch Plan include (in thousands): For the Years Ended December 31, 2024 2023 2022 Interest cost $ 1,403 $ 1,480 $ 581 Expected return on plan assets ( 1,178 ) ( 1,365 ) ( 545 ) Net periodic pension cost $ 225 $ 115 $ 36
Schedule of Expected Benefit Payments	Expected benefit payments to eligible participants under this plan for the next five years are as follows (in thousands): December 31, 2024 2025 $ 1,580 2026 $ 1,752 2027 $ 1,941 2028 $ 2,065 2029 $ 2,224 Succeeding five years $ 11,833

Equity (Tables)

Equity (Tables)	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	Amounts recognized, net of income taxes, in accumulated other comprehensive income (loss) consist of the following (in thousands): December 31, 2024 2023 Pension and other postretirement benefit plans - unrecognized prior service costs and net actuarial loss $ ( 5,890 ) $ ( 5,914 ) Interest rate swaps - net fair value gain 121 942 Total accumulated other comprehensive income (loss) $ ( 5,769 ) $ ( 4,972 )

Derivative Instruments and He_2

Derivative Instruments and Hedging Activities (Tables)	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)	The effect of the interest rate swaps on the consolidated statements of operations was as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 Income Statement Classification Derivatives designated as hedges: 5 year interest rate swap $ 57 $ 260 $ 343 Increase (decrease) to interest expense 10 year interest rate swap ( 1,097 ) ( 752 ) 655 Increase (decrease) to interest expense $ ( 1,040 ) $ ( 492 ) $ 998

Financial Instruments (Tables)

Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Summary of Fair Value Balances	The following table summarizes the fair value balances (in thousands): Fair Value Measurement at December 31, 2024 Total Level 1 Level 2 Level 3 Assets: Company owned life insurance policies (1) $ 25,435 $ — $ 25,435 $ — $ 25,435 $ — $ 25,435 $ — Liabilities: Deferred compensation liabilities $ 19,103 $ — $ 19,103 $ — $ 19,103 $ — $ 19,103 $ — Fair Value Measurement at December 31, 2023 Total Level 1 Level 2 Level 3 Assets: Company owned life insurance policies (1) $ 25,397 $ — $ 25,397 $ — $ 25,397 $ — $ 25,397 $ — Liabilities: Deferred compensation liabilities $ 17,299 $ — $ 17,299 $ — $ 17,299 $ — $ 17,299 $ — (1) Company owned life insurance policies have cash surrender value and are intended to assist in funding deferred compensation liabilities and other benefit plans.

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2024
Stock Based Compensation [Abstract]
Schedule of Nonvested Restricted Stock Units Activity	Non-vested restricted share awards outstanding as of December 31, 2023 and changes during the year under both the LTIP and the Director Plan are as follows: For the Year Ended December 31, 2024 Number of Shares Weighted Average Grant Date Fair Value per Share Non-vested at December 31, 2023 1,234,487 $ 24.71 Granted 900,907 $ 14.40 Vested ( 256,724 ) $ 28.19 Forfeited ( 308,955 ) $ 24.08 Non-vested at December 31, 2024 1,569,715 $ 18.35
Schedule of Employee Service Share-Based Compensation, Allocation of Recognized Period Costs	Stock-based compensation expense under both the LTIP and the Director Plan recognized in the consolidated statement of operations is as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 Cost of services and product sales $ 1,847 $ 4,625 $ 4,572 General and administrative expense 1,908 9,346 3,184 Total stock-based compensation expense $ 3,755 $ 13,971 $ 7,756

Other (Income) Expense, Net (Ta

Other (Income) Expense, Net (Tables)	12 Months Ended
	Dec. 31, 2024
Other Income and Expenses [Abstract]
Schedule of Other (Income) Expense, Net	The components of other (income) expense, net are as follows (in thousands): For the Years Ended December 31, 2024 2023 2022 Gain on sale of assets $ ( 1,779 ) $ ( 200 ) $ ( 1,068 ) Results of non-consolidated subsidiaries ( 236 ) ( 394 ) ( 294 ) Foreign exchange (gain) loss, net 1,197 176 229 Rents and royalties ( 1,922 ) ( 698 ) ( 709 ) Return on pension assets and other pension costs ( 1,178 ) ( 1,365 ) ( 545 ) Loss on lease abandonment and other exit costs 699 1,146 — Assets write-down 1,110 1,143 — Insurance and other settlements ( 8,432 ) ( 604 ) ( 669 ) Severance and other charges 985 — 3,332 ATM termination costs — 455 — Other, net ( 397 ) ( 509 ) ( 998 ) Total other (income) expense, net $ ( 9,953 ) $ ( 850 ) $ ( 722 )
Schedule of Foreign Exchange (Gain) Loss, Net	Foreign exchange (gain) loss, net is summarized in the following table (in thousands): For the Years Ended December 31, 2024 2023 2022 Angolan Kwanza $ ( 46 ) $ 188 $ ( 2 ) Australian Dollar ( 2 ) 81 9 British Pound 117 ( 408 ) 212 Canadian Dollar 293 156 238 Colombian Peso 62 92 ( 430 ) Euro 41 438 ( 382 ) Indonesian Rupiah 315 82 379 Nigerian Naira 126 ( 74 ) ( 39 ) Norwegian Krone ( 20 ) 103 ( 31 ) Russian Ruble 36 ( 375 ) 35 Turkish Lira 53 ( 472 ) 114 Other currencies, net 222 365 126 Foreign exchange (gain) loss, net $ 1,197 $ 176 $ 229

Earnings per Share (Tables)

Earnings per Share (Tables)	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Summary of Calculation of Weighted Average Common Shares Used in the Computation of Basic and Diluted Earnings per Share	The following table summarizes the calculation of weighted average common shares outstanding used in the computation of basic and diluted earnings per share (in thousands): For the Years Ended December 31, 2024 2023 2022 Weighted average common shares outstanding - basic 46,897 46,683 46,334 Effect of dilutive securities: Restricted shares 52 97 71 Performance shares 736 743 408 Weighted average common shares outstanding - diluted 47,685 47,523 46,813

Segment Reporting and Other D_2

Segment Reporting and Other Disaggregated Information (Tables)	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Summary of Financial Information of Operating Segments	Summarized financial information of our operating segments is shown in the following table (in thousands): As at and for the years ended: Reservoir Description Production Enhancement Corporate & Other (1) Consolidated December 31, 2024 CODM Measure - Revenue from unaffiliated clients $ 346,146 $ 177,702 $ — $ 523,848 Reconciliation of CODM measure - revenue from unaffiliated clients to segment operating income: Inter-segment revenue 123 214 ( 337 ) — Cost of services and product sales 269,169 151,916 ( 563 ) 420,522 Depreciation and amortization 10,660 4,293 — 14,953 General and administrative expense (2) 25,531 14,239 — 39,770 Other operating (income) expense, net (3) ( 11,542 ) 550 ( 158 ) ( 11,150 ) Foreign exchange (gain) loss, net (3) 985 306 ( 94 ) 1,197 CODM Measure - Segment operating income 51,466 6,612 478 58,556 Supplemental Disclosures: Total assets 322,764 149,446 118,196 590,406 Capital expenditures 11,413 1,318 297 13,028 December 31, 2023 CODM Measure - Revenue from unaffiliated clients $ 333,345 $ 176,445 $ — $ 509,790 Reconciliation of CODM measure - revenue from unaffiliated clients to segment operating income: Inter-segment revenue 156 249 ( 405 ) — Cost of services and product sales 256,480 145,194 ( 1,717 ) 399,957 Depreciation and amortization 11,462 4,322 — 15,784 General and administrative expense (2) 25,792 14,467 — 40,259 Other operating (income) expense, net (3) ( 994 ) ( 5 ) ( 27 ) ( 1,026 ) Foreign exchange (gain) loss, net (3) ( 278 ) 197 257 176 CODM Measure - Segment operating income 41,039 12,519 1,082 54,640 Supplemental Disclosures: Total assets 309,162 161,359 115,874 586,395 Capital expenditures 8,312 1,808 459 10,579 December 31, 2022 CODM Measure - Revenue from unaffiliated clients $ 307,691 $ 182,044 $ — $ 489,735 Reconciliation of CODM measure - revenue from unaffiliated clients to segment operating income: Inter-segment revenue 523 315 ( 838 ) — Cost of services and product sales 250,182 145,117 ( 1,644 ) 393,655 Depreciation and amortization 12,207 4,954 — 17,161 General and administrative expense (2) 24,264 13,853 — 38,117 Other operating (income) expense, net (3) ( 1,089 ) 1,414 ( 1,276 ) ( 951 ) Foreign exchange (gain) loss, net (3) ( 252 ) 670 ( 189 ) 229 CODM Measure - Segment operating income 22,902 16,351 2,271 41,524 Supplemental Disclosures: Total assets 307,108 159,628 111,618 578,354 Capital expenditures 7,458 2,181 577 10,216 (1) “Corporate and other” represents those items not directly related to a particular operating segment and eliminations. (2) General and administrative expense is presented as a total amount to the CODM and consists primarily of employee benefits, professional fees and information technology costs. (3) Other remaining balance is included in other (income) expense, net. See Note 19 - Other (income) expense, net for further detail.
Summary of Financial Information of Contracts	Summarized financial information of our contracts is shown in the following table (in thousands): For the Years Ended December 31, 2024 2023 2022 Reservoir Description Services $ 334,325 $ 322,921 $ 296,201 Production Enhancement Services 53,880 48,993 50,773 Total Revenue - Services $ 388,205 $ 371,914 $ 346,974 Reservoir Description Product sales $ 11,821 $ 10,424 $ 11,490 Production Enhancement Product sales 123,822 127,452 131,271 Total Revenue - Product sales $ 135,643 $ 137,876 $ 142,761 Total Revenue $ 523,848 $ 509,790 $ 489,735
Summary of Financial Information of Geographic Regions	Summarized financial information of our geographic regions is shown in the following table (in thousands): Other As at and for the years ended: United States Countries (1) (2) Consolidated December 31, 2024 Revenue $ 178,895 $ 344,953 $ 523,848 Property, plant and equipment, net 46,666 50,397 97,063 December 31, 2023 Revenue $ 178,549 $ 331,241 $ 509,790 Property, plant and equipment, net 50,792 48,834 99,626 December 31, 2022 Revenue $ 166,701 $ 323,034 $ 489,735 Property, plant and equipment, net 54,384 50,644 105,028 (1) Revenue earned in other countries, was not individually greater than 10 % of our consolidated revenue in 2024, 2023 and 2022 . (2) Property, plant and equipment, net in other countries, was not individually greater than 10 % of our consolidated property, plant and equipment, net in 2024, 2023 and 2022 .

Description of Business (Detail

Description of Business (Details)	12 Months Ended
	Dec. 31, 2024 Employee Office Country Segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of stores | Office	70
Number of countries in which entity operates | Country	50
Number of employees | Employee	3,500
Number of operating segments | Segment	2

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) $ / shares	Dec. 31, 2024 € / shares	Dec. 31, 2023 $ / shares
Significant Accounting Policies [Line Items]
Common stock, par value per share | $ / shares	$ 0.01		$ 0.01
Core Laboratories Inc. [Member]
Significant Accounting Policies [Line Items]
Amount decreased due to difference between the total par value of common shares | $	$ 0.7
Common stock, par value per share | (per share)	$ 0.01	€ 0.02

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Property, Plant and Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Significant Accounting Policies [Line Items]
Impairment charges relating long-lived asset held-for-use	$ 0	$ 0	$ 0

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Property, Plant and Equipment - Schedule of Property Plant and Equipment Useful life (Details)	Dec. 31, 2024
Buildings and Leasehold Improvements [Member] | Minimum [Member]
Property Plant And Equipment [Line Items]
Property, plant and equipment, useful life	3 years
Buildings and Leasehold Improvements [Member] | Maximum [Member]
Property Plant And Equipment [Line Items]
Property, plant and equipment, useful life	40 years
Machinery and Equipment [Member] | Minimum [Member]
Property Plant And Equipment [Line Items]
Property, plant and equipment, useful life	3 years
Machinery and Equipment [Member] | Maximum [Member]
Property Plant And Equipment [Line Items]
Property, plant and equipment, useful life	10 years

Acquisitions and Divestures - A

Acquisitions and Divestures - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Business Combinations [Abstract]
Goodwill, acquired during period	$ 0	$ 0	$ 0

Contract Assets and Liabiliti_3

Contract Assets and Liabilities - Contract Assets and Liabilities Changes in Net Contract Assets (Liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Contract assets
Current	$ 370	$ 1,293
Contract assets	370	1,293
Contract liabilities
Current	560	299
Contract liabilities	$ 560	$ 299

Contract Assets and Liabiliti_4

Contract Assets and Liabilities - Contract Assets and Liabilities Current and Long-term Contract Liabilities (Details 1) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 $ in Thousands	Dec. 31, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Contract liability	$ 560
Revenue, remaining performance obligation, expected timing of satisfaction, period	12 months

Contract Assets and Liabiliti_5

Contract Assets and Liabilities - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Impairment losses on contract assets	$ 0	$ 0	$ 0

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Finished goods	$ 27,127	$ 30,508
Parts and materials	28,953	37,670
Work in progress	3,322	3,524
Total inventories	$ 59,402	$ 71,702

Property, Plant and Equipment,

Property, Plant and Equipment, Net (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Land	$ 10,402	$ 10,652
Building and leasehold improvements	117,682	120,545
Machinery and equipment	283,296	284,225
Total property, plant and equipment	411,380	415,422
Less: Accumulated depreciation	(314,317)	(315,796)
Property, plant and equipment, net	$ 97,063	$ 99,626	$ 105,028

Leases - Schedule of Components

Leases - Schedule of Components of Lease Expense and Other Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Operating lease expense	$ 16,998	$ 17,454	$ 16,595
Short-term lease expense	1,720	1,768	1,784
Variable lease expense	1,719	1,758	1,414
Sublease income	(227)	(113)	0
Total lease expense	20,210	20,867	19,793
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows - operating leases payments	16,708	16,541	16,598
Right-of-use assets obtained in exchange for new lease obligations:
Right of use assets obtained in exchange for operating lease liabilities	$ 14,237	$ 17,005	$ 5,520
Weighted-average remaining lease term - operating leases	8 years 8 months 12 days	9 years 2 months 26 days	6 years 10 months 17 days
Weighted-average discount rate - operating leases	5.45%	5.32%	4.62%

Leases - Schedule of Undiscount

Leases - Schedule of Undiscounted Cash Flows for Non-cancellable Leases (Details) $ in Thousands	Dec. 31, 2024 USD ($)
Operating Leased Assets [Line Items]
2025	$ 13,245
2026	10,417
2027	8,324
2028	6,586
2029	4,388
Thereafter	25,505
Total undiscounted lease payments	68,465
Less: Imputed Interest	(14,432)
Total operating lease liabilities	54,033
2025	(231)
2026	(236)
2027	(241)
2028	(163)
2029	0
Thereafter	0
Total undiscounted lease payments	$ (871)

Intangibles and Goodwill - Sche

Intangibles and Goodwill - Schedule of Components of Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible asset, Gross Carrying Value	$ 25,729	$ 25,751
Intangible asset, Accumulated Amortization and Impairment	19,326	18,825
Acquired Trade Secrets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible asset, Gross Carrying Value	4,278	4,278
Intangible asset, Accumulated Amortization and Impairment	3,967	3,756
Acquired Patents and Technology [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible asset, Gross Carrying Value	15,722	15,744
Intangible asset, Accumulated Amortization and Impairment	14,243	13,953
Agreements Not to Compete [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible asset, Gross Carrying Value	1,105	1,105
Intangible asset, Accumulated Amortization and Impairment	1,105	1,105
Acquired Trade Names and Trademarks [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible asset, Gross Carrying Value	4,624	4,624
Intangible asset, Accumulated Amortization and Impairment	$ 11	$ 11
Minimum [Member] | Acquired Trade Secrets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible asset, Useful life in years	2 years
Minimum [Member] | Acquired Patents and Technology [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible asset, Useful life in years	4 years
Minimum [Member] | Agreements Not to Compete [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible asset, Useful life in years	2 years
Maximum [Member] | Acquired Trade Secrets [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible asset, Useful life in years	20 years
Maximum [Member] | Acquired Patents and Technology [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible asset, Useful life in years	15 years
Maximum [Member] | Agreements Not to Compete [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible asset, Useful life in years	5 years

Intangibles and Goodwill - Summ

Intangibles and Goodwill - Summary of Estimated Amortization Expense Related to Intangibles (Details) $ in Thousands	Dec. 31, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2025	$ 359
2026	231
2027	193
2028	98
2029	$ 35

Intangibles and Goodwill - Addi

Intangibles and Goodwill - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Carrying amount of goodwill	$ 99,445,000	$ 99,445,000
Changes in carrying amount of goodwill	0	0	$ 0
Reservoir Description Segment [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Carrying amount of goodwill	$ 99,400,000	$ 99,400,000

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income Before Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
United States	$ (11,045)	$ 3,907	$ (4,099)
Other countries	57,232	37,303	34,053
Income before income taxes	$ 46,187	$ 41,210	$ 29,954

Income Taxes - Schedule of In_2

Income Taxes - Schedule of Income Tax Expense Components (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Current:
United States	$ 1,231	$ 1,204	$ 1,269
Other countries	12,205	13,446	9,784
State and provincial	(22)	597	(100)
Total current	13,414	15,247	10,953
Deferred:
United States	(2,487)	1,555	(908)
Other countries	2,842	(12,343)	(162)
State and provincial	265	(274)	413
Total deferred	620	(11,062)	(657)
Income tax expense	$ 14,034	$ 4,185	$ 10,296

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Operating loss carryforwards	$ 28,800
Operating loss carryforwards, expiring in next three years	800
Operating loss carryforwards, expiring in years four, five and six	2,900
Operating loss carryforwards, expiring in years seven, eight and nine	3,200
Operating loss carryforwards, expiring thereafter	1,400
Deferred tax assets, operating loss carryforwards, not subject to expiration		$ 20,500
Expired net operating loss carryforwards	0
Unrecognized tax benefits, income tax penalties and interest expense	200	600	$ (200)
Unrecognized tax benefits, income tax penalties and interest accrued	5,100	4,900
Unrecognized tax benefits that would impact effective tax rate	400
Global intangible low taxed income	10,000	14,700
Subpart income	8,700	14,700
GILTI tax	2,100	3,100
Subpart F tax	$ 1,800	$ 3,100

Income Taxes - Schedule of In_3

Income Taxes - Schedule of Income Tax Reconciliation (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Tax at the statutory income tax rate (1)	[1]	$ 9,553	$ 8,139	$ 7,368
International earnings taxed at rates other than the statutory income tax rate (1)	[1]	2,237	5,749	5,923
Non-deductible expenses		1,092	2,168	3,096
Net operating loss		(190)	4,661	(3,627)
Foreign earnings currently taxed in the U.S.		3,934	3,077
Change in valuation allowance		337	(1,107)	1,943
State and provincial taxes		136	243	662
Tax credits		(5,823)	(7,410)	(6,872)
Unremitted earnings of subsidiaries		891	(14,464)	(27)
Adjustments of prior year taxes		(935)	701	(3,488)
Adjustments of income tax reserves		208	519	(184)
Foreign exchange		(964)	(171)	(576)
UK tax rate change		0	0	676
Accrued withholding taxes		3,262	1,639	1,883
Other		296	441	3,519
Income tax expense		$ 14,034	$ 4,185	$ 10,296
[1] Based on the U.S. statutory corporate income tax rate of 21 % for 2024 and 2023 and the Netherlands statutory income tax rate of 25 % for 2022.

Income Taxes - Schedule of In_4

Income Taxes - Schedule of Income Tax Reconciliation (Parenthetical) (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
U.S. statutory income tax rate	21%	21%
Netherlands statutory income tax rate			25%

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Tax Assets Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Deferred tax assets:
Net operating loss carry-forwards	$ 6,279	$ 7,814
Tax credit carry-forwards	5,811	2,144
Accruals for compensation	9,236	8,985
Accruals for inventory capitalization	1,673	1,621
Unrealized benefit from corporate restructuring	36,762	40,963
Intangibles	1,886	1,584
Unrealized benefit plan loss	962	1,224
Unrealized foreign exchange	2,819	2,875
Unearned revenue	2,632	3,453
Interest carry-forward	11,367	7,912
Other	1,074	1,401
Total deferred tax assets	80,501	79,976
Valuation allowance	(8,812)	(8,276)
Net deferred tax assets	71,689	71,700
Deferred tax liabilities:
Property, plant and equipment, net	(2,840)	(3,566)
Accrued withholding taxes	(11,279)	(10,466)
Unrealized foreign exchange	(1,542)	(988)
Other	(198)	(176)
Total deferred tax liabilities	(15,859)	(15,196)
Net deferred income taxes	55,830	56,504
Long-term deferred tax assets, net	69,613	69,201
Long-term deferred tax liabilities, net	(13,783)	(12,697)
Net deferred income taxes	$ 55,830	$ 56,504

Income Taxes - Schedule of In_5

Income Taxes - Schedule of Income Tax Contingency (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Unrecognized tax benefits at January 1,	$ 3,483	$ 3,509	$ 4,327
Tax positions, current period	138	144	230
Tax positions, prior period	(165)	68	(867)
Settlements with taxing authorities	0	0	(19)
Lapse of applicable statute of limitations	(184)	(238)	(162)
Unrecognized tax benefits at December 31,	$ 3,272	$ 3,483	$ 3,509

Other Assets - Schedule of Othe

Other Assets - Schedule of Other Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Table Text Block Supplement [Abstract]
Cash surrender value of life insurance policies	$ 25,435	$ 25,397
Investments in unconsolidated affiliates	5,080	4,844
Other	4,273	3,978
Total other assets	$ 34,788	$ 34,219

Long-Term Debt, Net - Additiona

Long-Term Debt, Net - Additional Information (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($) SeriesNote
Debt Instrument [Line Items]
Finance lease obligations	$ 0
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Finance lease obligations
Maturity date	Jul. 25, 2026
Number of series of debt issued | SeriesNote	2
Line of credit facility reduced minimum borrowing capacity	$ 50,000
Performance bonds under credit facility	10,800
Remaining borrowing capacity	106,100
Performance bonds	$ 7,600
Maximum [Member]
Debt Instrument [Line Items]
Basis spread on variable rate	3%
Minimum [Member]
Debt Instrument [Line Items]
Current borrowing capacity	$ 135,000
Basis spread on variable rate	2%
2021 Senior Notes Series A [Member]
Debt Instrument [Line Items]
Face amount	$ 45,000
Line of Credit [Member]
Debt Instrument [Line Items]
Interest coverage ratio, minimum	3%
Calculated covenant leverage ratio	1.31%
Calculated interest coverage ratio	6.74%
Line of Credit [Member] | Maximum [Member]
Debt Instrument [Line Items]
Maximum leverage ratio permitted	2.5
Line of Credit [Member] | Minimum [Member]
Debt Instrument [Line Items]
Maximum leverage ratio permitted	1
Series A and B of 2021 Senior Notes [Member]
Debt Instrument [Line Items]
Face amount	$ 110,000
Series A and B of 2023 Senior Notes [Member]
Debt Instrument [Line Items]
Face amount	$ 110,000

Long-Term Debt, Net - Schedule

Long-Term Debt, Net - Schedule of Long-term Debt Instruments (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Maturity date		Jul. 25, 2026
Total long-term debt		$ 128,000	$ 166,000
Less: Debt issuance costs		(1,889)	(2,866)
Long-term debt, net		126,111	163,134
Credit Facility [Member]
Debt Instrument [Line Items]
Total long-term debt		$ 18,000	56,000
Series A [Member] | 2021 Senior Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, interest rate	[1]	4.09%
Maturity date	[1]	Jan. 12, 2026
Total long-term debt	[1]	$ 45,000	45,000
Series A [Member] | 2023 Senior Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, interest rate	[2]	7.25%
Maturity date	[2]	Jun. 28, 2028
Total long-term debt	[2]	$ 25,000	25,000
Series B [Member] | 2021 Senior Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, interest rate	[1]	4.38%
Maturity date	[1]	Jan. 12, 2028
Total long-term debt	[1]	$ 15,000	15,000
Series B [Member] | 2023 Senior Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, interest rate	[2]	7.50%
Maturity date	[2]	Jun. 28, 2030
Total long-term debt	[2]	$ 25,000	$ 25,000
[1] Interest is payable semi-annually on June 30 and December 30. Interest is payable semi-annually on March 28 and September 28.

Pension and Other Postretirem_3

Pension and Other Postretirement Benefit Plans - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Assumptions used calculating benefit obligation, discount rate		3.48%	3.27%
Forecast [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected minimum funding requirements	$ 0.3

Pension and Other Postretirem_4

Pension and Other Postretirement Benefit Plans - Projected Benefit Obligation and Fair Value of Plan Asset (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Projected Benefit Obligation:
Projected benefit obligation at beginning of year	$ 43,985	$ 40,059
Interest cost	1,403	1,480	$ 581
Benefits paid and administrative expenses	(1,587)	(1,505)
Actuarial (gain) loss, net	(1,114)	2,905
Unrealized (gain) loss on foreign exchange	(2,018)	1,046
Projected benefit obligation at end of year	40,669	43,985	40,059
Fair Value of Plan Assets:
Fair value of plan assets at beginning of year	41,713	37,376
Increase (decrease) in plan asset value	12	3,137
Employer contributions	742	1,719
Unrealized gain (loss) on foreign exchange	(1,931)	986
Fair value of plan assets at end of year	38,949	41,713	$ 37,376
Under-funded status of the plan at end of the year	(1,720)	(2,272)
Accumulated Benefit Obligation	$ 40,669	$ 41,727

Pension and Other Postretirem_5

Pension and Other Postretirement Benefit Plans - Actuarial Assumptions Used to Determine the Actuarial Present Value of Projected Benefit Obligation and Net Periodic Pensions Costs (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Retirement Benefits [Abstract]
Weighted average assumed discount rate	3.48%	3.27%
Expected long-term rate of return on plan assets	3.48%	3.27%
Weighted average rate of compensation increase	2%	2.10%

Pension and Other Postretirem_6

Pension and Other Postretirement Benefit Plans - Schedule of Amounts Recognized in Balance Sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Deferred tax asset	$ 55,830	$ 56,504
Other long-term liabilities	20,732	20,040
Accumulated other comprehensive loss	(5,769)	(4,972)
Dutch Plan
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Deferred tax asset	440	582
Other long-term liabilities	1,720	2,272
Accumulated other comprehensive loss	$ (5,890)	$ (5,914)

Pension and Other Postretirem_7

Pension and Other Postretirement Benefit Plans - Schedule of Components of Net Periodic Pension Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Retirement Benefits [Abstract]
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax	Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax	Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax
Interest cost	$ 1,403	$ 1,480	$ 581
Expected return on plan assets	(1,178)	(1,365)	(545)
Net periodic pension cost	$ 225	$ 115	$ 36

Pension and Other Postretirem_8

Pension and Other Postretirement Benefit Plans - Schedule of Expected Benefit Payments (Details) $ in Thousands	Dec. 31, 2024 USD ($)
Retirement Benefits [Abstract]
2025	$ 1,580
2026	1,752
2027	1,941
2028	2,065
2029	2,224
Succeeding five years	$ 11,833

Pension and Other Postretirem_9

Pension and Other Postretirement Benefit Plans - Defined Contribution Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Retirement Benefits [Abstract]
Defined contribution plan, cost	$ 4.7	$ 4.3	$ 3.5

Pension and Other Postretire_10

Pension and Other Postretirement Benefit Plans - Deferred Compensation Arrangements (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Retirement Benefits [Abstract]
Base salary period used to determine benefit	5 years
Compensation expense	$ 0.9	$ 1.1	$ 1.4
Contributions by employer	$ 0.4	$ 0.4	$ 0.3

Equity - Additional Information

Equity - Additional Information (Details)				1 Months Ended	3 Months Ended			12 Months Ended
	Jan. 29, 2025 $ / shares	Feb. 01, 2024 USD ($)	Jun. 09, 2022 USD ($)	Feb. 08, 2019 shares	Dec. 31, 2024 $ / shares shares	Dec. 31, 2023 $ / shares shares	Dec. 31, 2022 $ / shares	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares	Dec. 31, 2024 € / shares shares
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Common stock, shares, issued					46,966,868	46,938,557		46,966,868	46,938,557		46,966,868
Common stock, par value per share | $ / shares					$ 0.01	$ 0.01		$ 0.01	$ 0.01
Common shares, vesting, stock based award								228,413
Treasury stock, shares, acquired				228				40,666,075
Treasury stock, value, acquired, cost method | $		$ 4,000						$ 1,700,000,000
Treasury stock acquired, average cost per share | $ / shares								$ 41.12
Treasury stock, shares, retired								33,475,406
Treasury stock, retired, cost method, amount | $								$ 1,200,000,000
Treasury stock (at cost)					140,048	82,021		140,048	82,021		140,048
Repurchase of common stock (shares)								286,440
Treasury stock, value | $								$ 5,306,000	$ 2,202,000	$ 3,903,000
Number of shares surrendered								109,224
Number of shares surrendered, Value | $								$ 2,000,000
Cash dividends per share | $ / shares					$ 0.01	$ 0.01	$ 0.01	$ 0.04	$ 0.04	$ 0.04
Common Shares [Member]
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Common shares, vesting, stock based award								28,311
Subsequent Event [Member]
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Cash dividends per share | $ / shares	$ 0.01
Subsequent Event [Member] | Quarterly Dividend [Member]
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Dividends payable, date declared	Jan. 29, 2025
Dividends payable, date of record	Feb. 10, 2025
Dividends payable, date to be paid	Mar. 03, 2025
ATM Program [Member] | Wells Fargo Securities, LLC [Member]
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Proceeds from issuance of common shares | $			$ 60,000,000
Core Laboratories Inc. [Member]
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Common stock, par value per share | (per share)					$ 0.01			$ 0.01			€ 0.02
Amount decreased due to difference between the total par value of common shares | $								$ 700,000
Equity related Transaction costs | $								$ 4,800,000

Equity - Schedule of Accumulate

Equity - Schedule of Accumulated Other Comprehensive Income (Loss) Net of Income Taxes (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Equity [Abstract]
Pension and other postretirement benefit plans - unrecognized prior service costs and net actuarial loss	$ (5,890)	$ (5,914)
Interest rate swaps - net fair value gain	121	942
Total accumulated other comprehensive income (loss)	$ (5,769)	$ (4,972)

Derivative Instruments and He_3

Derivative Instruments and Hedging Activities - Additional Information (Details) - USD ($) $ in Thousands		12 Months Ended
	Jun. 28, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Derivatives, Fair Value [Line Items]
Total long-term debt		$ 128,000	$ 166,000
Net gain included in AOCI expected to be reclassified into earnings	$ 10,000
Net gain included in accumulated other comprehensive income	400	100
Gain on forward interest rate swap agreements terminated and settlements		100
Long-term debt, percentage bearing fixed interest, amount		110,000
Long-term debt, percentage bearing variable interest, amount		18,000
Interest expense		12,369	13,430	$ 11,570
Credit Facility [Member]
Derivatives, Fair Value [Line Items]
Total long-term debt		$ 18,000	$ 56,000
2023 Senior Notes [Member]
Derivatives, Fair Value [Line Items]
Face amount	$ 50,000
Maximum [Member]
Derivatives, Fair Value [Line Items]
Basis spread on variable rate		3%
Maximum [Member] | Amended Credit Facility
Derivatives, Fair Value [Line Items]
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]		us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember
Basis spread on variable rate		3%
Maximum [Member] | 2023 Senior Notes [Member]
Derivatives, Fair Value [Line Items]
Derivative, fixed interest rate	7.50%
Minimum [Member]
Derivatives, Fair Value [Line Items]
Basis spread on variable rate		2%
Minimum [Member] | Amended Credit Facility
Derivatives, Fair Value [Line Items]
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]		us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember
Basis spread on variable rate		2%
Minimum [Member] | 2023 Senior Notes [Member]
Derivatives, Fair Value [Line Items]
Derivative, fixed interest rate	7.25%
Interest Rate Swap No. 1 [Member]
Derivatives, Fair Value [Line Items]
Derivative, notional amount		$ 25,000
Derivative, fixed interest rate		2.50%
Derivative, maturity date		Aug. 29, 2024
Interest Rate Swap No. 2 [Member]
Derivatives, Fair Value [Line Items]
Derivative, notional amount		$ 25,000
Derivative, fixed interest rate		1.30%
Derivative, maturity date		Feb. 28, 2025
Forward Interest Rate Swap [Member]
Derivatives, Fair Value [Line Items]
Derivative, notional amount		$ 60,000
Derivative, term of contract		10 years
Forward Interest Rate Swap [Member] | Maximum [Member]
Derivatives, Fair Value [Line Items]
Long term debt terms		11 years

Derivative Instruments and He_4

Derivative Instruments and Hedging Activities - Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Interest Rate Swap No. 1 [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gain (loss) on interest rate cash flow hedges	$ 57	$ 260	$ 343
Interest Rate Swap No. 2 [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gain (loss) on interest rate cash flow hedges	(1,097)	(752)	655
Interest Rate Swap [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gain (loss) on interest rate cash flow hedges	$ (1,040)	$ (492)	$ 998

Financial Instruments - Summary

Financial Instruments - Summary of Fair Value Balances (Details) - USD ($) $ in Thousands		Dec. 31, 2024	Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Company owned life insurance policies	[1]	$ 25,435	$ 25,397
Deferred compensation plan, assets		25,435	25,397
Deferred compensation liabilities		19,103	17,299
Deferred compensation plan, liability		19,103	17,299
Fair Value, Inputs, Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Company owned life insurance policies	[1]	25,435	25,397
Deferred compensation plan, assets		25,435	25,397
Deferred compensation liabilities		19,103	17,299
Deferred compensation plan, liability		$ 19,103	$ 17,299
[1] (1) Company owned life insurance policies have cash surrender value and are intended to assist in funding deferred compensation liabilities and other benefit plans.

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands					12 Months Ended
		Feb. 15, 2024	Feb. 16, 2023	Feb. 17, 2022	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation, net of awards issued (shares)					228,413
Number of additional shares authorized (shares)					28,311
Stock-based compensation					$ 3,755	$ 13,971	$ 7,756
Granted (shares)					900,907
General and Administrative Expense	[1]				$ 39,770	40,259	38,117
Executive Management [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation					$ 3,500	6,500	3,900
Total Restricted Stock Award [Member] | Restricted Stock Units (RSUs) [Member] | Director Stock Award Program [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for grant (shares)					436,340
Total Restricted Stock Award [Member] | Restricted Stock Units (RSUs) [Member] | Employee Stock Award Program [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for grant (shares)					1,569,741
Performance Share Award Program [Member] | Restricted Stock Units (RSUs) [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Recognized stock compensation expense reversed					$ 4,600
Total award issued during the period					112,389
Value of total award issued during the period					$ 3,000
Performance Share Award Program [Member] | Restricted Stock Units (RSUs) [Member] | Employee Stock Award Program [Member] | Performance Share Award Program 2022 Grant [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Granted (shares)				362,254
Allocated share-based compensation expense, net of tax					$ 9,300
Award vesting period					3 years
Allocated share-based compensation expense						1,200	6,400
Shares surrendered to settle personal tax liability				69,116
Stock comp shares surrendered, value				$ 1,200
Stock comp shares surrendered, per share price (USD per share)				$ 17.31
Performance Share Award Program [Member] | Restricted Stock Units (RSUs) [Member] | Employee Stock Award Program [Member] | Performance Share Award Program 2023 Grant[ Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Granted (shares)			507,410
Allocated share-based compensation expense, net of tax					$ 12,300
Award vesting period					3 years
Allocated share-based compensation expense					$ 400	8,400
Compensation cost not yet recognized, period for recognition					12 months
Estimated expense reduced during the period					$ 1,200
Performance Share Award Program [Member] | Restricted Stock Units (RSUs) [Member] | Employee Stock Award Program [Member] | Performance Share Award Program 2024 Grant [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Granted (shares)		830,785
Allocated share-based compensation expense, net of tax					$ 11,800
Award vesting period					3 years
Allocated share-based compensation expense					$ 4,400
Compensation cost not yet recognized, period for recognition					24 months
Restricted Share Award Program [Member] | Restricted Stock Units (RSUs) [Member] | Director Stock Award Program [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation					$ 800	$ 900	$ 1,000
Granted (shares)					55,902	38,514	32,910
Award vesting period					1 year	1 year	1 year
Compensation cost not yet recognized, period for recognition					3 months
Compensation cost not yet recognized					$ 200
Grants, fair value					1,000	$ 900	$ 1,000
Restricted Share Award Program [Member] | Restricted Stock Units (RSUs) [Member] | Employee Stock Award Program [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation					$ 2,700	$ 3,900	$ 4,500
Granted (shares)					14,220	180,450	25,500
Award vesting period					6 years
Compensation cost not yet recognized, period for recognition					46 months
Compensation cost not yet recognized					$ 4,600
Grants, fair value					200	$ 3,600	$ 500
Vested in period, intrinsic value					$ 3,400	$ 4,100	$ 5,300
Maximum [Member] | Total Restricted Stock Award [Member] | Restricted Stock Units (RSUs) [Member] | Director Stock Award Program [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares authorized (shares)					14,100,000
Number of shares available for grant (shares)					1,400,000
[1] (2) General and administrative expense is presented as a total amount to the CODM and consists primarily of employee benefits, professional fees and information technology costs.

Stock-Based Compensation by Pay

Stock-Based Compensation by Payment Award (Details)	12 Months Ended
	Dec. 31, 2024 $ / shares shares
Stock Based Compensation [Abstract]
Non-vested, share, beginning | shares	1,234,487
Granted (shares) | shares	900,907
Vested (shares) | shares	(256,724)
Forfeited (shares) | shares	(308,955)
Non-vested, share, end | shares	1,569,715
Nonvested, weighted average grant date fair value, beginning (USD per share) | $ / shares | $ / shares	$ 24.71
Grants in period, weighted average grant date fair value (USD per share) | $ / shares | $ / shares	14.4
Vested in period, weighted average grant date fair value (USD per share) | $ / shares | $ / shares	28.19
Forfeited in period, weighted average grant date fair value (USD per share) | $ / shares | $ / shares	24.08
Nonvested, weighted average grant date fair value, end (USD per share) | $ / shares | $ / shares	$ 18.35

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Employee Service Share-Based Compensation, Allocation of Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	$ 3,755	$ 13,971	$ 7,756
Cost of services and sales, exclusive of depreciation [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	1,847	4,625	4,572
General and adminstrative expense, exclusive of depreciation [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation	$ 1,908	$ 9,346	$ 3,184

Impairment and Other Charges -

Impairment and Other Charges - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Asset Impairment Charges [Abstract]
Impairment charges relating long-lived asset held-for-use	$ 0	$ 0	$ 0
Impairments of indefinite lived intangible assets or goodwill	$ 0	$ 0	$ 0

Other (Income) Expense, Net - S

Other (Income) Expense, Net - Schedule of Other (Income) Expense, Net (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Other Income Expense [Line Items]
Gain on sale of assets		$ (1,779)	$ (200)	$ (1,068)
Results of non-consolidated subsidiaries		(236)	(394)	(294)
Foreign exchange (gain) loss, net	[1]	1,197	176	229
Rents and royalties		(1,922)	(698)	(709)
Return on pension assets and other pension costs		(1,178)	(1,365)	(545)
Loss on lease abandonment and other exit costs		699	1,146	0
Assets write-down		1,110	1,143	0
Insurance and other settlements		(8,432)	(604)	(669)
Severance and other charges		985	0	3,332
ATM termination costs		0	455	0
Other, net		(397)	(509)	(998)
Total other (income) expense, net		$ (9,953)	$ (850)	$ (722)
[1] (3) Other remaining balance is included in other (income) expense, net. See Note 19 - Other (income) expense, net for further detail.

Other (Income) Expense, Net - A

Other (Income) Expense, Net - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Other Income Expense [Line Items]
Loss on Lease Abandonment and Other Exit Costs	$ 699	$ 1,146	$ 0
Assets write-down	1,110	1,143	0
Partial insurance settlements	8,432	604	669
Cost incurred and loss of income	4,000
Net gain on property, plant and equipment	4,400
Partial Distribution from North America mid-continent winter storm			700
Expropriation settlement from related party		600
ATM Program [Member]
Other Income Expense [Line Items]
Written off previously deferred cost		$ 500
Mineral rights
Other Income Expense [Line Items]
Gain on sale of assets	$ 1,400		$ 700

Other (Income) Expense, Net - F

Other (Income) Expense, Net - Foreign Exchange (Gain) Loss, Net (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Other Income Expense [Line Items]
Foreign exchange (gain) loss, net	[1]	$ 1,197	$ 176	$ 229
Angolan Kwanza [Member]
Other Income Expense [Line Items]
Foreign exchange (gain) loss, net		(46)	188	(2)
Australian Dollar [Member]
Other Income Expense [Line Items]
Foreign exchange (gain) loss, net		(2)	81	9
British Pound [Member]
Other Income Expense [Line Items]
Foreign exchange (gain) loss, net		117	(408)	212
Canadian Dollar [Member]
Other Income Expense [Line Items]
Foreign exchange (gain) loss, net		293	156	238
Colombian Peso [Member]
Other Income Expense [Line Items]
Foreign exchange (gain) loss, net		62	92	(430)
Euro [Member]
Other Income Expense [Line Items]
Foreign exchange (gain) loss, net		41	438	(382)
Indonesia Rupiah [Member]
Other Income Expense [Line Items]
Foreign exchange (gain) loss, net		315	82	379
Nigerian Naira [Member]
Other Income Expense [Line Items]
Foreign exchange (gain) loss, net		126	(74)	(39)
Norwegian Krone [Member]
Other Income Expense [Line Items]
Foreign exchange (gain) loss, net		(20)	103	(31)
Russian Ruble [Member]
Other Income Expense [Line Items]
Foreign exchange (gain) loss, net		36	(375)	35
Turkish Lira [Member]
Other Income Expense [Line Items]
Foreign exchange (gain) loss, net		53	(472)	114
Other Currencies, Net [Member]
Other Income Expense [Line Items]
Foreign exchange (gain) loss, net		$ 222	$ 365	$ 126
[1] (3) Other remaining balance is included in other (income) expense, net. See Note 19 - Other (income) expense, net for further detail.

Earnings per Share - Summary of

Earnings per Share - Summary of Calculation of Weighted Average Common Shares Used in the Computation of Basic and Diluted Earnings per Share (Details) - shares shares in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Earnings Per Share [Abstract]
Weighted average common shares outstanding - basic	46,897	46,683	46,334
Restricted shares	52	97	71
Performance shares	736	743	408
Weighted average common shares outstanding - diluted	47,685	47,523	46,813

Segment Reporting and Other D_3

Segment Reporting and Other Disaggregated Information - Summary of Financial Information of Operating Segments (Details) $ in Thousands		12 Months Ended
		Dec. 31, 2024 USD ($) Segment	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | Segment		2
Revenue		$ 523,848	$ 509,790	$ 489,735
Cost of services and product sales		420,522	399,957	393,655
Depreciation and amortization		14,953	15,784	17,161
General and Administrative Expense	[1]	39,770	40,259	38,117
Other operating (income) expense, net		(9,953)	(850)	(722)
Foreign exchange (gain) loss, net	[2]	1,197	176	229
CODM Measure - Segment operating income		58,556	54,640	41,524
Supplemental Disclosures:
Total assets		590,406	586,395	578,354
Capital expenditures		13,028	10,579	10,216
Operating Segments [Member]
Segment Reporting Information [Line Items]
Other operating (income) expense, net	[2]	(11,150)	(1,026)	(951)
Intersegment Eliminations [Member]
Segment Reporting Information [Line Items]
Revenue		0	0	0
Reservoir Description [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue		346,146	333,345	307,691
Cost of services and product sales		269,169	256,480	250,182
Depreciation and amortization		10,660	11,462	12,207
General and Administrative Expense	[1]	25,531	25,792	24,264
Other operating (income) expense, net	[2]	(11,542)	(994)	(1,089)
Foreign exchange (gain) loss, net	[2]	985	(278)	(252)
CODM Measure - Segment operating income		51,466	41,039	22,902
Supplemental Disclosures:
Total assets		322,764	309,162	307,108
Capital expenditures		11,413	8,312	7,458
Reservoir Description [Member] | Intersegment Eliminations [Member]
Segment Reporting Information [Line Items]
Revenue		123	156	523
Production Enhancement [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue		177,702	176,445	182,044
Cost of services and product sales		151,916	145,194	145,117
Depreciation and amortization		4,293	4,322	4,954
General and Administrative Expense	[1]	14,239	14,467	13,853
Other operating (income) expense, net	[2]	550	(5)	1,414
Foreign exchange (gain) loss, net	[2]	306	197	670
CODM Measure - Segment operating income		6,612	12,519	16,351
Supplemental Disclosures:
Total assets		149,446	161,359	159,628
Capital expenditures		1,318	1,808	2,181
Production Enhancement [Member] | Intersegment Eliminations [Member]
Segment Reporting Information [Line Items]
Revenue		214	249	315
Corporate and Other [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenue	[3]	0	0	0
Cost of services and product sales	[3]	(563)	(1,717)	(1,644)
Depreciation and amortization	[3]	0	0	0
General and Administrative Expense	[1],[3]	0	0	0
Other operating (income) expense, net	[2],[3]	(158)	(27)	(1,276)
Foreign exchange (gain) loss, net	[2],[3]	(94)	257	(189)
CODM Measure - Segment operating income	[3]	478	1,082	2,271
Supplemental Disclosures:
Total assets	[3]	118,196	115,874	111,618
Capital expenditures	[3]	297	459	577
Corporate and Other [Member] | Intersegment Eliminations [Member]
Segment Reporting Information [Line Items]
Revenue	[3]	$ (337)	$ (405)	$ (838)
[1] (2) General and administrative expense is presented as a total amount to the CODM and consists primarily of employee benefits, professional fees and information technology costs. (3) Other remaining balance is included in other (income) expense, net. See Note 19 - Other (income) expense, net for further detail. (1) “Corporate and other” represents those items not directly related to a particular operating segment and eliminations.

Segment Reporting and Other D_4

Segment Reporting and Other Disaggregated Information - Summary of Financial Information of Contracts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenue from External Customer [Line Items]
Revenue	$ 523,848	$ 509,790	$ 489,735
Service [Member]
Revenue from External Customer [Line Items]
Revenue	388,205	371,914	346,974
Service [Member] | Reservoir Description [Member]
Revenue from External Customer [Line Items]
Revenue	334,325	322,921	296,201
Service [Member] | Production Enhancement [Member]
Revenue from External Customer [Line Items]
Revenue	53,880	48,993	50,773
Product [Member]
Revenue from External Customer [Line Items]
Revenue	135,643	137,876	142,761
Product [Member] | Reservoir Description [Member]
Revenue from External Customer [Line Items]
Revenue	11,821	10,424	11,490
Product [Member] | Production Enhancement [Member]
Revenue from External Customer [Line Items]
Revenue	$ 123,822	$ 127,452	$ 131,271

Segment Reporting and Other D_5

Segment Reporting and Other Disaggregated Information - Summary of Financial Information of Geographic Regions (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue		$ 523,848	$ 509,790	$ 489,735
Property, plant and equipment, net		97,063	99,626	105,028
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue		178,895	178,549	166,701
Property, plant and equipment, net		46,666	50,792	54,384
Other Countries [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	[1],[2]	344,953	331,241	323,034
Property, plant and equipment, net	[1],[2]	$ 50,397	$ 48,834	$ 50,644
[1] Property, plant and equipment, net in other countries, was not individually greater than 10 % of our consolidated property, plant and equipment, net in 2024, 2023 and 2022 . Revenue earned in other countries, was not individually greater than 10 % of our consolidated revenue in 2024, 2023 and 2022 .

Segment Reporting and Other D_6

Segment Reporting and Other Disaggregated Information - Summary of Financial Information of Geographic Regions (Parenthetical) (Details) - Maximum [Member]	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of Property, plant and equipment, net	10%	10%	10%
Revenue [Member] | Geographic Concentration Risk [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Percentage of Revenue earned in other countries	10%	10%	10%

Schedule II - Valuation and Q_2

Schedule II - Valuation and Qualifying Account (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Reserve for doubtful accounts, start		$ 2,280	$ 2,214	$ 3,225
Additions Charged to /(Recovered from)Expense		1,203	179	(6)
Write-offs		(298)	(113)	(1,006)
Other	[1]	7	0	1
Reserve for doubtful accounts, end		$ 3,192	$ 2,280	$ 2,214
[1] (1) Comprised primarily of differences due to changes in exchange rate.